好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

2009 Annual Meeting | Poster Session 05

Wednesday 04/29/09
11:30 AM - 02:30 PM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Scientific Poster Session
Cerebrovascular Disease and Interventional Neurology, History of Neurology, Movement Disorders, Aging and Dementia, Epilepsy, Ethics, Pain and Palliative Care, MS and Related Diseases, Neurologic 好色先生, Peripheral Nerve
No CME available
Event Timeline
11:30 AM - 02:30 PM Abstract 001 - Actors or Real Patients: Which Is Better for Medical Student 好色先生?
11:30 AM - 02:30 PM Abstract 002 - Choosing a Neurology Residency Program: What Variables Are Important? A Survey Study
11:30 AM - 02:30 PM Abstract 003 - Neurology Residency Training Programs in Argentina
11:30 AM - 02:30 PM Abstract 004 - Neurological Grand Rounds: Current State of Affairs
11:30 AM - 02:30 PM Abstract 005 - Mayo Brothers on the Six Core Competencies: A Theoretical Look Back into the Future
11:30 AM - 02:30 PM Abstract 006 - Searching for Unicorns: The Neurologist as Diagnostician for Rare Disorders
11:30 AM - 02:30 PM Abstract 007 - The Clinician-Educator's Portfolio: Needs Assessment and Information Dissemination
11:30 AM - 02:30 PM Abstract 008 - Automated Data Mining: An Innovative and Efficient Web Based Approach To Maintain Resident Case Logs
11:30 AM - 02:30 PM Abstract 009 - Parkinson's Disease on the Internet: An Evaluation of the Readability, Quality, and Technical Content of Patient Information
11:30 AM - 02:30 PM Abstract 010 - FrontalCortex.com: A Website for Online Learning in Neurology
11:30 AM - 02:30 PM Abstract 011 - A Shared Solution for Delivering a Uniformed Curriculum to Neurology Residents in Geographically Distinct Locations
11:30 AM - 02:30 PM Abstract 012 - Geriatric Neurology Web Module for Third-Year Neurology Clerkship
11:30 AM - 02:30 PM Abstract 013 - Ranolazine Attenuates Complete Freund's Adjuvant-Induced Mechanical Hyperalgesia
11:30 AM - 02:30 PM Abstract 014 - Differences in Pain Parameters among Patients with Complex Regional Pain Syndrome, Lumbar or Cervical Radiculopathy and Healthy Controls
11:30 AM - 02:30 PM Abstract 015 - Neurologic Safety of Treatment with NGX-4010, a High-Concentration Capsaicin Patch, in Patients with Postherpetic Neuralgia
11:30 AM - 02:30 PM Abstract 016 - TRO19622, a Mitochondrial Targeted Neuroprotective Compound, Prevents and Reverses Paclitaxel-Induced Painful Peripheral Neuropathy
11:30 AM - 02:30 PM Abstract 017 - A Double-Blinded, Placebo-Controlled, Cross over Study of Ketamine, Fentanyl and Diazepam in Experimental Pain in 21 Healthy Males
11:30 AM - 02:30 PM Abstract 018 - Mental Motor Imagery as an Index of Arm and Leg Pain Severity
11:30 AM - 02:30 PM Abstract 019 - Long-Term Treatment of Diabetic Neuropathy with Lacosamide: Results from Two Long-Term Open-Label Trials
11:30 AM - 02:30 PM Abstract 020 - Milnacipran Has Low Potential for Drug-Drug Interactions
11:30 AM - 02:30 PM Abstract 021 - Identification of Symptom Clusters in Patients with Fibromyalgia
11:30 AM - 02:30 PM Abstract 022 - Pregabalin in Fibromyalgia - Systematic Review of Efficacy and Safety from Company Clinical Trial Reports
11:30 AM - 02:30 PM Abstract 023 - The Effect of Milnacipran on Cognitive Function and Fatigue in Fibromyalgia Patients
11:30 AM - 02:30 PM Abstract 024 - The Effect of Milnacipran on Pain Modulation in Fibromyalgia: An fMRI Analysis
11:30 AM - 02:30 PM Abstract 025 - The Quicksand of Forgetfulness - Semantic Dementia in One Hundred Years of Solitude
11:30 AM - 02:30 PM Abstract 026 - Silas Weir Mitchell and His Research on the Cerebellum
11:30 AM - 02:30 PM Abstract 027 - Association of Mercurial Exposure in Leo Kanner's Original Case Series Entitled Autistic Disturbances of Affective Contact
11:30 AM - 02:30 PM Abstract 028 - Does Susac's Syndrome Explain Goya's Artistic Evolution?
11:30 AM - 02:30 PM Abstract 029 - The Contribution of Ibn Zuhr (Avenaor) to the Progress of Neuroscience
11:30 AM - 02:30 PM Abstract 030 - Contribution of Near Eastern Scholars to Neurology: El Zahrawi (Albucasis) 993-1064 AD
11:30 AM - 02:30 PM Abstract 031 - Yeast Therapy for Beriberi and Pellagra
11:30 AM - 02:30 PM Abstract 032 - The Tripartite Origins of the Asymmetric Tonic Reflex: Gesell, Gerstmann and Magnus
11:30 AM - 02:30 PM Abstract 033 - Contributions of Wilford Hall Medical Center to the Field of Neurology
11:30 AM - 02:30 PM Abstract 034 - The Vaccine Panic That Wasn't
11:30 AM - 02:30 PM Abstract 035 - Jean-Martin Charcot: Sarcasm and Skepticism
11:30 AM - 02:30 PM Abstract 036 - The First Steps of Clinical Neurology in Argentina
11:30 AM - 02:30 PM Abstract 037 - Sin City and Show Girls: The Genesis for Lumbar Microdiscectomy
11:30 AM - 02:30 PM Abstract 038 - Mens Imperator: New Thoughts on the Old Problem of Caligula's 'Madness'
11:30 AM - 02:30 PM Abstract 039 - The Stepping Test - A Historical Review
11:30 AM - 02:30 PM Abstract 040 - Medical Researcher William Brebner: Occupational Exposure from a Monkey Bite Resulting in Fatal Herpes B Virus Encephalomyelitis in New York City in 1932
11:30 AM - 02:30 PM Abstract 041 - Botulinum Toxin (Type A) for the Treatment of Diabetic Peripheral Neuropathic Pain
11:30 AM - 02:30 PM Abstract 042 - Impact of Postherpetic Neuralgia (PHN) and Painful Diabetic Peripheral Neuropathy (DPN) on Healthcare Costs
11:30 AM - 02:30 PM Abstract 043 - Time to Opioid Use among Patients with Diabetic Peripheral Neuropathic Pain Who Initiated Duloxetine Versus Other Treatments
11:30 AM - 02:30 PM Abstract 044 - Ultrastructural Study of the Phrenic Nerve in Streptozotocin-Induced Diabetic Rats: Effects of Insulin Treatment
11:30 AM - 02:30 PM Abstract 045 - A New Marker for Chronic Demyelination in Diabetic Neuropathy
11:30 AM - 02:30 PM Abstract 046 - Clinical, Electrophysiologic and Skin Biopsy Findings in Cryptogenic Sensorimotor Polyneuropathy Compared to Diabetic Polyneuropathy and Normal Controls
11:30 AM - 02:30 PM Abstract 047 - Efficacy and Safety of Tapentadol ER for Diabetic Peripheral Neuropathic Pain: Results of a Randomized-Withdrawal, Double-Blind, Placebo-Controlled Phase III Study
11:30 AM - 02:30 PM Abstract 048 - Axonal Polyneuropathies: Aetiologies and Relevance of Paraclinical Investigations in a Cohort of 420 Patients
11:30 AM - 02:30 PM Abstract 049 - Neuropathy in a Population with Inflammatory Bowel Disease in Olmstead County, Minnesota
11:30 AM - 02:30 PM Abstract 050 - A Prospective Controlled Population-Based Radiographic Study of Lower Limb Arterial Calcification in Patients with and without Diabetes Mellitus and Risk Covariates
11:30 AM - 02:30 PM Abstract 051 - Leprosy Neuropathy: Clinical and Electrophysiological Evaluation before and after Multidrug Therapy
11:30 AM - 02:30 PM Abstract 052 - Nerve Conduction Studies in Leprosy Contactants
11:30 AM - 02:30 PM Abstract 053 - Characteristics of the Mononeuropathy Multiplex Associated with Acute Parvovirus B19 Infection
11:30 AM - 02:30 PM Abstract 054 - Chemotherapy-Related Polyneuropathy Effect on Quality of Life in Patients with Lymphoma
11:30 AM - 02:30 PM Abstract 055 - Pain Contributes to Motor Symptoms in Carpal Tunnel Syndrome
11:30 AM - 02:30 PM Abstract 056 - Pregabalin Is Effective in the Treatment of Posttraumatic Peripheral Neuropathic Pain
11:30 AM - 02:30 PM Abstract 057 - The Distribution of Lesions among 281 Neuralgic Amyotrophy Patients
11:30 AM - 02:30 PM Abstract 058 - The Demographic Features of Neuralgic Amyotrophy
11:30 AM - 02:30 PM Abstract 059 - Predictors of Neuropathy after Lung Transplantation
11:30 AM - 02:30 PM Abstract 060 - Self-Mutilation in a Patient with Mitochondrial Disease
11:30 AM - 02:30 PM Abstract 061 - Objective Measurements of Rigidity in Parkinson's Disease after Subthalamic Nucleus Stimulation
11:30 AM - 02:30 PM Abstract 062 - Response of Periodic Limb Movements While Awake (PLMW) to Intra-Operative Pallidal Stimulation: Case Report and Video
11:30 AM - 02:30 PM Abstract 063 - Greater Improvements across Quality of Life Domains Following Unilateral Deep Brain Stimulation Surgery in the GPi as Compared to the STN: Results from a Randomized, Controlled Trial in Parkinson Disease
11:30 AM - 02:30 PM Abstract 064 - A Controlled Study of the Long-Term Cognitive Outcome of Bilateral Subthalamic Nucleus Deep Brain Stimulation
11:30 AM - 02:30 PM Abstract 065 - Longitudinal Change in Apathy Following Deep Brain Stimulation for Parkinson's Disease
11:30 AM - 02:30 PM Abstract 066 - Resonance in Subthalamo-Cortical Circuits in Parkinson's Disease
11:30 AM - 02:30 PM Abstract 067 - Differential Effects of 5 Hz and 1 Hz Premotor Repetitive Transcranial Magnetic Stimulation (rTMS) on Cortical Excitability and Physical Fatigability in PD
11:30 AM - 02:30 PM Abstract 069 - STN Stimulation Effects on Pneumophonic Coordination in Parkinson's Disease: An Acoustic and Aerodynamic Study
11:30 AM - 02:30 PM Abstract 070 - Weight Changes Associated with Unilateral STN DBS and Advanced PD
11:30 AM - 02:30 PM Abstract 071 - Weight Change Following Deep Brain Stimulation for Movement Disorders
11:30 AM - 02:30 PM Abstract 072 - Study of Orthostatic Regulation in Patients with Parkinson's Disease Receiving Deep Brain Stimulation
11:30 AM - 02:30 PM Abstract 073 - Long Term Efficacy with Vagus Nerve Stimulation in Adults and the Elderly with Refractory Epilepsy: A Comparative Analysis
11:30 AM - 02:30 PM Abstract 074 - Seizure Incidence and EEG Characteristics in the Pediatric Stroke Population
11:30 AM - 02:30 PM Abstract 075 - Neuroimaging Findings in Children with Benign Focal Epileptiform Discharges
11:30 AM - 02:30 PM Abstract 076 - Dose Response to Oxcarbazepine in Children with Newly Diagnosed Partial Epilepsy
11:30 AM - 02:30 PM Abstract 077 - Population Pharmacokinetics of Lacosamide in Subjects with Partial-Onset Seizures: Results from Two Phase III Trials
11:30 AM - 02:30 PM Abstract 078 - Assessment of Phenytoin Use for In-Hospital Seizures at an Academic Medical Center
11:30 AM - 02:30 PM Abstract 079 - Carisbamate as Adjunctive Treatment for Partial Onset Seizures in Adults: Pharmacokinetic/Pharmacodynamic Modeling of Efficacy Based on Three Randomized, Placebo-Controlled Trials
11:30 AM - 02:30 PM Abstract 080 - Behavioral Treatment Can Reduce Seizures and Improve Quality of Life for Epilepsy Patients
11:30 AM - 02:30 PM Abstract 081 - Safety and Tolerability of Lacosamide: A Summary of Adverse Events in Epilepsy Clinical Trials
11:30 AM - 02:30 PM Abstract 082 - Diurnal Seizure Periodicity in Primary Idiopathic and Symptomatic Generalized Epilepsies
11:30 AM - 02:30 PM Abstract 083 - Epilepsy Cost of Illness in the U.S. Privately Insured
11:30 AM - 02:30 PM Abstract 084 - UCB Antiepileptic Drug Pregnancy Registry
11:30 AM - 02:30 PM Abstract 085 - Evaluating FDA Bioequivalence Standards for Generic Carbamazepine Formulations
11:30 AM - 02:30 PM Abstract 086 - Comparison of Two Classifications of Postoperative Seizure Outcome, Engel vs ILAE Classification, Following Epilepsy Surgery in Adults with Medically Refractory Epilepsy
11:30 AM - 02:30 PM Abstract 087 - Utility of the Measurement of Monoamine Neurotransmitter Metabolites and Other Specific Biomarkers in CSF from Infants and Children with Early Onset Epilepsy
11:30 AM - 02:30 PM Abstract 088 - Attitudes to Epilepsy Surgery in Jamaican Patients with Localization-Related Epilepsy
11:30 AM - 02:30 PM Abstract 089 - Cingulate Gyrus Epilepsy: Clinical, Neurphysiological and Behavioral Aspects with Surgical Outcomes
11:30 AM - 02:30 PM Abstract 090 - The Effects of Conversion from Enzyme-Inducing Anticonvulsants to Topiramate on Serum Lipids and C-Reactive Protein
11:30 AM - 02:30 PM Abstract 091 - Differential Effects of Rufinamide in Adults with Partial Onset Seizures as a Function of Concomitant Antiepileptic Drug Therapy: A Post-Hoc Analysis
11:30 AM - 02:30 PM Abstract 092 - Refractory Status Epilepticus (RSE) in Developing Country: Experience from a Tertiary Care Centre from South India
11:30 AM - 02:30 PM Abstract 093 - Cerebral Venous Thrombosis: Clinical Presentation and Outcome in a Prospective Series
11:30 AM - 02:30 PM Abstract 094 - Stroke Arrival Time to a Tertiary Care Emergency Room in Islamabad, Pakistan - Quick Enough but of No Gain
11:30 AM - 02:30 PM Abstract 095 - Left Atrial Enlargement in Relationship to Atrial Fibrillation and Other Demographic Factors in Acute Ischemic Stroke and TIA Patients
11:30 AM - 02:30 PM Abstract 096 - Barriers in Seeking Early Stroke Treatment: Assessment of an Urban Underserved Population
11:30 AM - 02:30 PM Abstract 097 - Bilateral Thalamic Infarction Treatment with Modafinil
11:30 AM - 02:30 PM Abstract 098 - Stroke in Generation X: Etiology and Clinical Outcome of Stroke in Patients under 45 Years
11:30 AM - 02:30 PM Abstract 099 - Urban Versus Rural Trends in tPA Use for Acute Ischemic Stroke in Washington State
11:30 AM - 02:30 PM Abstract 100 - The Influence of Age on Racial Disparities in Stroke in South Carolina
11:30 AM - 02:30 PM Abstract 101 - LuNAR Strokes: Late Night Activity Regarding Stroke Codes
11:30 AM - 02:30 PM Abstract 102 - Frequency and Association of Coexisting Heart Failure on Stroke Outcomes in the United States: 1995-2005
11:30 AM - 02:30 PM Abstract 103 - Increased Mortality for Weekend Admission for Subarachnoid Hemorrhage (SAH) or Intracranial Hemorrhage (ICH)
11:30 AM - 02:30 PM Abstract 104 - Are Hispanics at Higher Risk of Symptomatic Intracranial Hemorrhage after tPA for Acute Ischemic Stroke? The Combined UT- Houston and UCSD Experience
11:30 AM - 02:30 PM Abstract 105 - Gender and Ischemic Stroke among Alaska Native People: Similar Risk Profile and Outcomes
11:30 AM - 02:30 PM Abstract 106 - Racial Differences in Ischemic Stroke Subtype Classification: An MRI-Based Approach
11:30 AM - 02:30 PM Abstract 107 - Asymptomatic Peripheral Arterial Disease Predicts Vascular Events in Stroke/TIA Patients
11:30 AM - 02:30 PM Abstract 108 - Emergency Department Misdiagnosis of Cerebrovascular Events in the Era of Modern Neuroimaging: A Systematic Review
11:30 AM - 02:30 PM Abstract 109 - Incidence of Stroke and Stroke Subtypes in a Multi-Ethnic Population. Results from Stroke among Hispanic and African-American Regional Populations (SHARP) Study
11:30 AM - 02:30 PM Abstract 110 - Stroke in Young, Asian Women; Risk Factors, Sub Types, Presentation and Outcome
11:30 AM - 02:30 PM Abstract 111 - The Occurrence of Stroke in an Adult Cohort of Sickle Cell Disease Patients
11:30 AM - 02:30 PM Abstract 112 - Cholesterol Level and Hemorrhagic Transformation after Ischemic Stroke
11:30 AM - 02:30 PM Abstract 113 - Predictors of Cerebral Ischemic Events in Patients with Asymptomatic Carotid Artery Stenosis: Systematic Review
11:30 AM - 02:30 PM Abstract 114 - Non-Invasive Positive Airway Pressure for Primary Stroke Prevention in Obstructive Sleep Apnea
11:30 AM - 02:30 PM Abstract 115 - A Retrospective Analysis of Antithrombotic Use in the Peri-Procedural Period of Colonoscopy in Stroke and TIA Patient
11:30 AM - 02:30 PM Abstract 116 - Blood Pressure as a Predictor of Poor Functional Outcome in a Puerto Rican Stroke Cohort
11:30 AM - 02:30 PM Abstract 117 - Sex Difference in Arterial Stiffness and Correlation with Systolic Blood Pressure
11:30 AM - 02:30 PM Abstract 118 - Antithrombotic Medication Utilization and Relationship to Outcomes among Patients with Carotid Dissection in United States
11:30 AM - 02:30 PM Abstract 119 - Informal Advice Can Influence How and When TIA Patients Present for Medical Assessment
11:30 AM - 02:30 PM Abstract 120 - Association of ABCD2 Score with the Presence of Steno-Occlusive Disease among Patients with Transient Ischemic Attacks
11:30 AM - 02:30 PM Abstract 121 - Is Cognition Differentially Affected in Female Versus Male Multiple Sclerosis Patients?
11:30 AM - 02:30 PM Abstract 122 - Cognitive Impairment in Multiple Sclerosis Early after the Second Episode Does Not Predict Disability 5 Years Later
11:30 AM - 02:30 PM Abstract 123 - A Retrospective Analysis in Patients with Relapsing-Remitting Multiple Sclerosis - Results of the Data Collection in Multiple Sclerosis "TYPIC"
11:30 AM - 02:30 PM Abstract 124 - Long Term Effect of Interferon-Beta on Disease Severity in Relapsing-Remitting Multiple Sclerosis Patients
11:30 AM - 02:30 PM Abstract 125 - Longitudinal Worsening in Fatigue Is Not Associated with Cognitive Deterioration in Multiple Sclerosis
11:30 AM - 02:30 PM Abstract 126 - Long-Term Effects of Interferon Beta-1a Dose on Relapse Rate in Relapsing-Remitting Multiple Sclerosis: Results from a Post-Hoc Analysis of PRISMS Study Data
11:30 AM - 02:30 PM Abstract 128 - Natalizumab Reduces Clinical and MRI Disease Activity in Second Line Treatment of Relapsing Remitting Multiple Sclerosis: Results of a Multicenter Study
11:30 AM - 02:30 PM Abstract 129 - Comparison of Multiple Sclerosis (MS) Relapses and Total Medical Costs for Users of Glatiramer Acetate and Beta Interferons: Two-Year Analysis of a U.S. Managed Care Database
11:30 AM - 02:30 PM Abstract 130 - Cognitive Aspects in Relapsing Remitting Multiple Sclerosis (RRMS) Patients Treated with Immunomodulant Drugs: 24-Month Follow-Up of the ITACA Study
11:30 AM - 02:30 PM Abstract 131 - The Interferon Beta-1b 16-Year Long-Term Follow-Up Study: Measuring Efficacy after Controlling for Bias in Long-Term Follow-Up Trials
11:30 AM - 02:30 PM Abstract 132 - A Clinical Retrospective Report on Mitoxantrone Treatment in Active Multiple Sclerosis Patients
11:30 AM - 02:30 PM Abstract 133 - A Post-Hoc Analysis of Cumulative Dose Effects of Subcutaneous Interferon Beta-1a on Clinical and MRI Outcomes in Relapsing-Remitting Multiple Sclerosis: Results over the Long Term
11:30 AM - 02:30 PM Abstract 134 - Suspected Cardiotoxicity during Mitoxantrone Treatment for Multiple Sclerosis in British Columbia, Canada
11:30 AM - 02:30 PM Abstract 135 - Effect of Natalizumab on Relapse Outcomes in Patients with Relapsing MS Who Experience MRI Activity during Treatment
11:30 AM - 02:30 PM Abstract 136 - Treatment with Oral Fingolimod (FTY720), 0.5 or 1.25 mg, for 14 Days Has No Effect on Airway Resistance
11:30 AM - 02:30 PM Abstract 137 - Improvement in Quality-of-Life Outcomes with Natalizumab in Multiple Sclerosis Patients with Highly Active Disease
11:30 AM - 02:30 PM Abstract 138 - Improved Quality of Life in Patients with Relapsing-Remitting Multiple Sclerosis on Long-Term Intramuscular Interferon Beta-1a: A 15-Year Study
11:30 AM - 02:30 PM Abstract 139 - Comparing Patient-Reported and Physician-Reported EDSS Scores in Patients from ASSURANCE
11:30 AM - 02:30 PM Abstract 140 - The Efficacy of Natalizumab in Patients with Relapsing Multiple Sclerosis in a Clinical Practice Setting
11:30 AM - 02:30 PM Abstract 141 - Acute and Chronic Response to Levodopa in Diffuse Lewy Body Disease (DLB)
11:30 AM - 02:30 PM Abstract 142 - Effect of Subcutaneous Interferon Beta-1a on Multiple Sclerosis Severity: Findings from the PRISMS Study
11:30 AM - 02:30 PM Abstract 143 - Multiple Sclerosis: Cognitive Function Evaluated by Computerized Cognitive Assessment Battery
11:30 AM - 02:30 PM Abstract 144 - Change in Health-Related Quality of Life in Multiple Sclerosis Patients Receiving Natalizumab
11:30 AM - 02:30 PM Abstract 145 - Factors Influencing Quality of Life and Coping Processes of Patients with Multiple Sclerosis: Baseline Data of an International, Observational Study
11:30 AM - 02:30 PM Abstract 146 - Which Is the Best Indication to Early Treat with Interferon [beta] the Clinically Isolated Syndromes Based on the Clinical Onset? A Cochrane Metanalysis
11:30 AM - 02:30 PM Abstract 147 - Extensive Erosive Dermatitis Associated with Hypereosinophilia under Natalizumab Treatement
11:30 AM - 02:30 PM Abstract 148 - Immunomodulatory Drug Treatment in Multiple Sclerosis: Effect on Survival
11:30 AM - 02:30 PM Abstract 149 - Development of a New Semantic Category Assessment Instrument in the Global/Local Processing: Preliminary Data of Multiple Sclerosis Subjects
11:30 AM - 02:30 PM Abstract 150 - The Effect of Disease Modifying Therapy on Disability Status in a Longitudinal Retrospective Analysis of a Multiple Sclerosis Center Database
11:30 AM - 02:30 PM Abstract 151 - Cognitive Impairment and Mental Fatigue in Multiple Sclerosis and Myasthenia Gravis
11:30 AM - 02:30 PM Abstract 152 - Use of MRI in Clinical Decision-Making in Multiple Sclerosis
11:30 AM - 02:30 PM Abstract 153 - Health Care Utilization and Cost Comparison of Patients with Multiple Sclerosis Treated with Natalizumab or Interferon Beta 1a SC: A Propensity Score Matched Analysis
11:30 AM - 02:30 PM Abstract 154 - Long Term Improvement in the Disability of Worsening MS Patients with Plasma Exchange: Results of a 25 Year Follow up Study
11:30 AM - 02:30 PM Abstract 155 - Clinical Course in Multiple Sclerosis Patients Presenting with a History of Progressive Disease
11:30 AM - 02:30 PM Abstract 156 - Correlation between N-acteylaspartate (NAA) Levels and RNFL Thickness Measures in a Large Multiple Sclerosis (MS) Cohort
11:30 AM - 02:30 PM Abstract 157 - Diffusion Tensor and Magnetization Transfer MRI of the Human Optic Nerve In Vivo Correlates with Retinal Nerve Fiber Layer Thickness in Multiple Sclerosis
11:30 AM - 02:30 PM Abstract 158 - Associations between Retinal Nerve Fiber Layer Abnormalities and Neurologists' Assessments of Optic Disc Pallor and Afferent Pupillary Defects
11:30 AM - 02:30 PM Abstract 159 - Low-Contrast Letter Acuity Scores Correlate Better with Severity of Multiple Sclerosis
11:30 AM - 02:30 PM Abstract 160 - Evidence for Axonal Loss and Prominent Color Vision Deficits in Children with Multiple Sclerosis or Clinically Isolated Syndrome
11:30 AM - 02:30 PM Abstract 161 - Retinal Nerve Fibre Layer Thickness and Optic Nerve Lesions in Acute Monosymptomatic Optic Neuritis
11:30 AM - 02:30 PM Abstract 162 - A Comparison of Cirrus vs. Stratus Optical Coherence Tomography for Measuring Retinal Changes
11:30 AM - 02:30 PM Abstract 163 - Reproducibility of Cirrus Optical Coherence Tomography (OCT) in Multiple Sclerosis
11:30 AM - 02:30 PM Abstract 164 - Reproducibility of Serial Optical Coherence Tomography without Pharmacologic Pupillary Dilatation
11:30 AM - 02:30 PM Abstract 165 - Adverse Impact of Visual Comorbidities on Visual Disability in MS
11:30 AM - 02:30 PM Abstract 166 - Visual Quality of Life and Its Correlates for Patients with Multiple Sclerosis
11:30 AM - 02:30 PM Abstract 167 - Roles of 好色先生 and Medial Temporal Atrophy in the Diagnosis of Amnestic MCI and Mild Dementia
11:30 AM - 02:30 PM Abstract 168 - Time Course of Diagnostic Features of Lewy Body Disease
11:30 AM - 02:30 PM Abstract 169 - The ADAS-cog's Performance as a Measure - Lessons from the ADNI Study: Part 2 - Evaluation Using Modern Psychometric Methods
11:30 AM - 02:30 PM Abstract 170 - A Phase III, Placebo-Controlled, Double-Blind, Randomized Trial Assessing the Effect of Tramiprosate on Hippocampus Volume Change in Patients with Mild-to-Moderate Alzheimer's Disease (The Alphase Study)
11:30 AM - 02:30 PM Abstract 171 - How Well Does the ADAS-cog Measure the Spectrum of Alzheimer's Disease Severity? An Item Response Theory Analysis
11:30 AM - 02:30 PM Abstract 172 - Long Term Cognitive Impairment, MRI Findings and History of Coronary Artery Bypass Grafting Surgery (CABG)
11:30 AM - 02:30 PM Abstract 173 - White Matter Hyperintensities Are Associated with Impaired Attention and Gait in Normally Functioning Elderly Subjects
11:30 AM - 02:30 PM Abstract 174 - Screening for REM Sleep Behavior Disorder in Patients with Cognitive Impairment and/or Parkinsonism: Updated Validation Data on the Mayo Sleep Questionnaire
11:30 AM - 02:30 PM Abstract 175 - Two Distinct Variants of Right Temporal Frontotemporal Lobar Degeneration
11:30 AM - 02:30 PM Abstract 176 - Mild Cognitive Impairment +/- Subsequent Dementia Associated with Underlying Lewy Body Disease
12:00 PM - 01:30 PM Break
Faculty Disclosures
Chelsea S. Kidwell, MD No disclosure on file
Joseph I. Sirven, MD, FAAN Dr. Sirven has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Sirven has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurelis. Dr. Sirven has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurona. Dr. Sirven has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. Dr. Sirven has received publishing royalties from a publication relating to health care. Dr. Sirven has received personal compensation in the range of $10,000-$49,999 for serving as a Host/ Co producer with WJCT Public Media. Dr. Sirven has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant with Federal Aviation Administration .
Aaron E. Miller, MD, FAAN Dr. Miller has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Accordant Health Services (Caremark). Dr. Miller has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Corevitas (formerly known as Corrona). Dr. Miller has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for MAPI=Pharma. Dr. Miller has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Viatris (Mylan). Dr. Miller has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint Global. Dr. Miller has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gerson Lehrman Group. Dr. Miller has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen Idec. Dr. Miller has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alexion. Dr. Miller has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amgen (Horizon Therapeutics). Dr. Miller has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Sterne Kessler. Dr. Miller has received publishing royalties from a publication relating to health care.
Gretchen L. Birbeck, MD, MPH, DTMH, FAAN An immediate family member of Dr. Birbeck has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various. Dr. Birbeck has a non-compensated relationship as a Ambassador for Zambia with RSTMH that is relevant to AAN interests or activities.
Michael R. Sperling, MD, FAAN Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurelis. The institution of Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB Pharma. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medscape. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for International Medical Press. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Projects for Knowledge. The institution of Dr. Sperling has received research support from SK Life Science. The institution of Dr. Sperling has received research support from UCB Pharma . The institution of Dr. Sperling has received research support from Takeda. The institution of Dr. Sperling has received research support from Neurelis. The institution of Dr. Sperling has received research support from Engage Therapeutics . The institution of Dr. Sperling has received research support from Medtronic. The institution of Dr. Sperling has received research support from Cavion. The institution of Dr. Sperling has received research support from Xenon Pharma. The institution of Dr. Sperling has received research support from Cerevel. The institution of Dr. Sperling has received research support from National Institutes of Health . The institution of Dr. Sperling has received research support from DARPA. Dr. Sperling has received publishing royalties from a publication relating to health care. Dr. Sperling has received publishing royalties from a publication relating to health care. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Vice President with Epilepsy Consortium .
Elaine Wyllie, MD Dr. Wyllie has received publishing royalties from a publication relating to health care.
Ronald C. Petersen, MD, PhD, FAAN Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly and Co.. Dr. Petersen has received personal compensation in the range of $0-$499 for serving as a Consultant for Eisai, Inc.. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Nordisk. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has a non-compensated relationship as a Board of Directors with American Brain Foundation that is relevant to AAN interests or activities.
Michael Silber, MB, ChB, FAAN Dr. Silber has received publishing royalties from a publication relating to health care. Dr. Silber has received personal compensation in the range of $500-$4,999 for serving as a Topic writer with UpToDate.
David L. Tirschwell, MD, FAAN Dr. Tirschwell has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Scientific. The institution of Dr. Tirschwell has received research support from Abbott. The institution of Dr. Tirschwell has received research support from NIH.
Joseph Jankovic, MD, FAAN Dr. Jankovic has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Motric Bio. Dr. Jankovic has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. The institution of Dr. Jankovic has received research support from Michael J Fox Foundation for Parkinson Research;. The institution of Dr. Jankovic has received research support from Dystonia Coalition. The institution of Dr. Jankovic has received research support from Parkinson's Foundation.
Elliot M. Frohman, MD, FAAN Dr. Frohman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Janssen. Dr. Frohman has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Janssen. Dr. Frohman has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Up To Date. Dr. Frohman has received publishing royalties from a publication relating to health care.
J. E. Ahlskog, MD, PhD Dr. Ahlskog has received publishing royalties from a publication relating to health care.
Jeffrey A. Cohen, MD Dr. Cohen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Convelo. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astoria. Dr. Cohen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viatris. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PSI. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shionogi. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celltrion.
Joseph F. Drazkowski, MD, FAAN Dr. Drazkowski has nothing to disclose.
David W. Dodick, MD, FAAN Dr. Dodick has received personal compensation for serving as an employee of Mayo Clinic. Dr. Dodick has received personal compensation for serving as an employee of Atria Health. Dr. Dodick has received personal compensation for serving as an employee of Thomas Jefferson University . Dr. Dodick has received personal compensation for serving as an employee of Norwegian University of Science and Technology. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen. Dr. Dodick has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Allergan. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biopharm Communications. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eli Lilly. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Inside Practice Australia. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clinical 好色先生 Alliance. Dr. Dodick has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Headache Cooperative of the Pacific . Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medica Communications. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MJ Healthcare. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nocira. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Praxis. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Revance . Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Synapse Medical Communications. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vector Psychometrics. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as a Consultant for Ayya Biosciences. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as a Consultant for Theranica. Dr. Dodick has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Atria. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for WebMD. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Thomas Jefferson University. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medforce. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Precision HEOR. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Canadian Headache Society. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Headache Cooperative of New England. Dr. Dodick has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen Japan. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for KingDevick Technologies. Dr. Dodick has received personal compensation in the range of $1,000,000+ for serving as an officer or member of the Board of Directors for Precon Health. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Ontologics. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Matterhorn. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Axon Therapeutics. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Cephalgia Group. Dr. Dodick has stock in Healint. Dr. Dodick has stock in Theranica. Dr. Dodick has stock in Aural Analytics . Dr. Dodick has stock in Epien. Dr. Dodick has stock in Matterhorn. Dr. Dodick has stock in Ontologics. Dr. Dodick has stock in Precon Health. Dr. Dodick has stock in King Devick Technologies. Dr. Dodick has stock in Nocira. Dr. Dodick has stock in Exsano. Dr. Dodick has stock in Palion. Dr. Dodick has stock in AYYA Biosciences. Dr. Dodick has stock in Perfood. Dr. Dodick has stock in Cephalgia Group. Dr. Dodick has stock in Atria Health. Dr. Dodick has stock in Man and Science. Dr. Dodick has stock in Eigenlyfe. An immediate family member of Dr. Dodick has stock in ScotiaLyfe. Dr. Dodick has stock in Axon Therapeutics. The institution of Dr. Dodick has received research support from Department of Defense. The institution of Dr. Dodick has received research support from Patient Centered Outcomes Research Institute. The institution of Dr. Dodick has received research support from Henry Jackson Foundation. Dr. Dodick has received intellectual property interests from a discovery or technology relating to health care. Dr. Dodick has received intellectual property interests from a discovery or technology relating to health care. Dr. Dodick has received intellectual property interests from a discovery or technology relating to health care. Dr. Dodick has received publishing royalties from a publication relating to health care. Dr. Dodick has received publishing royalties from a publication relating to health care. Dr. Dodick has received publishing royalties from a publication relating to health care. Dr. Dodick has a non-compensated relationship as a Chair with American Brain Foundation that is relevant to AAN interests or activities. Dr. Dodick has a non-compensated relationship as a Committee member/Course Director with 好色先生 that is relevant to AAN interests or activities. Dr. Dodick has a non-compensated relationship as a Chair/Immediate Past Chair with American Migraine Foundation that is relevant to AAN interests or activities. Dr. Dodick has a non-compensated relationship as a Chair Global Patient Advocacy Coalition with International Headache Society that is relevant to AAN interests or activities.
Bruce L. Miller, MD, FAAN Dr. Miller has nothing to disclose.
Daniel Pelletier, MD Dr. Pelletier has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Pelletier has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi Genzyme. Dr. Pelletier has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Pelletier has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Polpharma Biologics.
Jacqueline French, MD, FAAN Dr. French has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for Epilepsy Foundation. The institution of Dr. French has received research support from Epilepsy Study Consortium/ Epilepsy Foundation (Funded by UCB). The institution of Dr. French has received research support from GW/One8 Foundation/FACES. The institution of Dr. French has received research support from NINDS. The institution of Dr. French has received research support from Xenon. The institution of Dr. French has received research support from Cerevel. The institution of Dr. French has received research support from FACES. The institution of Dr. French has received research support from UCB. The institution of Dr. French has received research support from Epilepsy Study Consortium. The institution of Dr. French has received research support from UCB. The institution of Dr. French has received research support from Praxis. Dr. French has received personal compensation in the range of $50,000-$99,999 for serving as a Chief Medical/Innovation Officer with Epilepsy Foundation. Dr. French has a non-compensated relationship as a Consultant with Acadia Pharmaceuticals Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Access Industries that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Acuta Capital Partners LLC that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with AFASCI Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Agrithera, Inc. that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Alkermes that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Alterity Therapeutics Limited that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Angelini Pharma S.p.A. that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Autifony Therapeutics Limited that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Axonis Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Bain Capital that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Beacon Biosciences that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Biogen that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Biohaven Pharma that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Bloom Science, Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Bright Minds Biosciences, Inc. that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Capsidia Biotherapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Cerebral Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Cerecin, Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, SAB with Cerevel that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting, SAB with Cognizance Biomarkers that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting with Ceribell that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Cowen that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Crossject that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Advisory Board with EcoR1 Capital that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with EG 427 that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant, Advisory Board with Eisai that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Encoded Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant/Advisory Board with Engrail that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Epitel, Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with EpiMinder that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Grin Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Harmony that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Advisory Board with Ionis Pharmaceutical that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with iQure Pharma, Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with IQVIA that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Janssen Pharma that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Jazz Pharmaceutical that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Leal Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, with Livanova that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, SAB with London Research & Pharmaceuticals that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Longboard Pharmaceutical that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Maplight Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Marinus that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Medscape/Web MD that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Modulight Bio that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Montara Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Mosaica Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Neumarker that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Neumirna Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Neurelis that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consulting, Advisory Board with Neurocrine that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Neuropace that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with NeuroPro Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting with Neuroventis that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting with Neurona Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting, Advisory Board with Neuvarti that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Noema that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting with Ono Pharmaceutical that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting, Advisory Board with Otsuka that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consulting, Advisory Board with Ovid Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting with Praxis that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with PureTech LYT Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with QurAlis Corp that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Rapport Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Receptor Holdings, Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Rivervest Venture Partners that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Sage Therapeutics, Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with SK Life Science that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Stoke that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Stream Neuroscience that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Supernus that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Takeda that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Taysha Gene Therapies that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with UCB, Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with uniQure that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Ventus Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Vida Ventures Management that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Xenon Pharmaceuticals that is relevant to AAN interests or activities.
David J. Capobianco, MD, FAAN No disclosure on file
Peter Goadsby, MD, PhD, FRS Dr. Goadsby has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva Pharmaceuticals. Dr. Goadsby has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Satsuma. Dr. Goadsby has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shiratronics. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CoolTech LLC. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Linpharma. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PureTech Health LLC. Dr. Goadsby has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Kallyope. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Seaport Therapeutics. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dr Reddy's. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Orion Pharma. Dr. Goadsby has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ipsen. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Massachusetts Medical Society. The institution of Dr. Goadsby has received research support from NIHR. Dr. Goadsby has received publishing royalties from a publication relating to health care. Dr. Goadsby has received publishing royalties from a publication relating to health care. Dr. Goadsby has a non-compensated relationship as a Trustee with Migraine Trust that is relevant to AAN interests or activities. Dr. Goadsby has a non-compensated relationship as a Trustee with Organisation for Understanding Cluster Headache (UK) that is relevant to AAN interests or activities.
Rachelle S. Doody, MD, PhD Dr. Doody has received personal compensation for serving as an employee of F. Hoffman-LaRoche. Dr. Doody has stock in F. Hoffman-LaRoche.
Virgilio Gerald H. Evidente, MD, FAAN Dr. Evidente has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Revance. Dr. Evidente has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Evidente has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Supernus. Dr. Evidente has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva. Dr. Evidente has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medtronic. Dr. Evidente has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neurocrine. Dr. Evidente has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amneal. Dr. Evidente has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. The institution of Dr. Evidente has received research support from CND. The institution of Dr. Evidente has received research support from Aeon. The institution of Dr. Evidente has received research support from Bukwang Pharmaceuticals. The institution of Dr. Evidente has received research support from Jazz Pharmaceuticals. The institution of Dr. Evidente has received research support from Scion Neurostim. The institution of Dr. Evidente has received research support from Theravance Biopharma. Dr. Evidente has received research support from Cerevance. Dr. Evidente has received research support from Ipsen. The institution of Dr. Evidente has received research support from Vima Pharmaceuticals. The institution of Dr. Evidente has received research support from Biohaven.
Bradley F. Boeve, MD, FAAN Dr. Boeve has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Rainwater Charitable Foundation. The institution of Dr. Boeve has received research support from Alector. The institution of Dr. Boeve has received research support from EIP Pharma. The institution of Dr. Boeve has received research support from Transposon. The institution of Dr. Boeve has received research support from Cognition Therapeutics. Dr. Boeve has received publishing royalties from a publication relating to health care.
Laura J. Balcer, MD, MSCE, FAAN An immediate family member of Dr. Balcer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Children's Hospital of Philadelphia.
Asa J. Wilbourn, MD No disclosure on file
Misha-Miroslav Backonja, MD Dr. Backonja has nothing to disclose.
Wieslaw J. Oczkowski, MD Dr. Oczkowski has nothing to disclose.
Richard M. Dubinsky, MD, MPH, FAAN Dr. Dubinsky has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie Pharmaceuticals. An immediate family member of Dr. Dubinsky has stock in Abbvie and Abbott Labs. The institution of Dr. Dubinsky has received research support from CHDI. The institution of Dr. Dubinsky has received research support from Prilenia. The institution of Dr. Dubinsky has received research support from Sage Pharmaceuticals. The institution of Dr. Dubinsky has received research support from NIH/NINDS. Dr. Dubinsky has a non-compensated relationship as a Member, independent data safety monitoring board with Roche that is relevant to AAN interests or activities.
Nathan B. Fountain, MD, FAAN Dr. Fountain has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amylyx. Dr. Fountain has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Coda. Dr. Fountain has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Fountain has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Fountain has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eisai. Dr. Fountain has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Fountain has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BrainStorm. Dr. Fountain has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Shackleford. Dr. Fountain has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for Acumen. Dr. Fountain has stock in Hexokine.
Stephen L. Hauser, MD Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NGM Bio. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Moderna. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BD. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pheno Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nurix Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gilead. Dr. Hauser has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Accure. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alector. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hinge Therapeutics. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Neurona. Dr. Hauser has a non-compensated relationship as a Clinical Trial/Primary Investigator with Roche that is relevant to AAN interests or activities. Dr. Hauser has a non-compensated relationship as a Clinical Trial/Primary Investigator with Novartis that is relevant to AAN interests or activities.
James C. Grotta, MD, FAAN Dr. Grotta has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Frazer Ltd. Dr. Grotta has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Haemonetics. Dr. Grotta has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acticor. Dr. Grotta has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Prolong Pharma. Dr. Grotta has received publishing royalties from a publication relating to health care. Dr. Grotta has received publishing royalties from a publication relating to health care.
Michael K. Racke, MD Dr. Racke has received personal compensation for serving as an employee of Quest Diagnostics. Dr. Racke has or had stock in Quest Diagnostics.Dr. Racke has received intellectual property interests from a discovery or technology relating to health care.
Hubert H. Fernandez, MD, FAAN Dr. Fernandez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Fernandez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Fernandez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Intrance. Dr. Fernandez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Fernandez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Fernandez has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Fernandez has received publishing royalties from a publication relating to health care. Dr. Fernandez has received personal compensation in the range of $10,000-$49,999 for serving as a Steering Committee/Advisory Committee Member with Parkinson Study Group.
Amer Alshekhlee, MD No disclosure on file
Joab Chapman, MD, PhD Dr. Chapman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Mapi Pharma. Dr. Chapman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Dr. Chapman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merk Serono. The institution of Dr. Chapman has received research support from Ministry Of Industry.
Hamza I. Maqsood, MD Dr. Qureshi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AstraZeneca.
Douglas J. Lanska, MD, FAAN Dr. Lanska has received personal compensation for serving as an employee of Ministry of Health of the Russian Federation. Dr. Lanska has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MedScape 好色先生. Dr. Lanska has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Medlink Neurology. Dr. Lanska has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Ebix/Oakstone Publishing. Dr. Lanska has received publishing royalties from a publication relating to health care. Dr. Lanska has received personal compensation in the range of $500-$4,999 for serving as a Invited speaker with Mayo Clinic.
Richard J. Barohn, MD, FAAN Dr. Barohn has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for NuFactor. The institution of Dr. Barohn has received research support from FDA OPD R01. Dr. Barohn has received intellectual property interests from a discovery or technology relating to health care.
Barry S. Oken, MD, PhD, FAAN Dr. Oken has nothing to disclose.
Harry B. Coslett, MD, FAAN The institution of Dr. Coslett has received research support from NIDCD, NINDS, NIA. Dr. Coslett has received publishing royalties from a publication relating to health care.
John Shoffner IV, MD No disclosure on file
Dennis N. Bourdette, MD, FAAN Dr. Bourdette has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Magellan Health Care. Dr. Bourdette has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Best Doctor's Inc. Dr. Bourdette has stock in Authobahn Therapeutics. Dr. Bourdette has received intellectual property interests from a discovery or technology relating to health care.
Joseph E. Parisi, MD Dr. Parisi has nothing to disclose.
Ilo Leppik, MD Dr. Leppik has nothing to disclose.
Jau-Shin Lou, MD, PhD, FAAN Dr. Lou has nothing to disclose.
Neill R. Graff-Radford, MD, FAAN The institution of Dr. Graff-Radford has received research support from Biogen. The institution of Dr. Graff-Radford has received research support from Lilly. The institution of Dr. Graff-Radford has received research support from Eisai. The institution of Dr. Graff-Radford has received research support from Biogen. Dr. Graff-Radford has received publishing royalties from a publication relating to health care.
Ray L. Watts, MD, FAAN No disclosure on file
Emmanuelle Waubant, MD, PhD, FAAN The institution of Dr. Waubant has received research support from NIH. The institution of Dr. Waubant has received research support from NMSS. The institution of Dr. Waubant has received research support from PCORI. The institution of Dr. Waubant has received research support from Race to Erase MS. The institution of Dr. Waubant has received research support from Roche. The institution of Dr. Waubant has received research support from Department of Defense. Dr. Waubant has received publishing royalties from a publication relating to health care.
Anne H. Cross, MD, FAAN Dr. Cross has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Cross has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech / F. Hoffman la Roche. Dr. Cross has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Cross has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for TG Therapeutics. Dr. Cross has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb . Dr. Cross has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octave. Dr. Cross has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Cross has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Cross has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Cross has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Cross has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Cross has received personal compensation in the range of $5,000-$9,999 for serving as an officer or member of the Board of Directors for Consortium of MS Centers. Dr. Cross has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. The institution of Dr. Cross has received research support from Genentech. Dr. Cross has received intellectual property interests from a discovery or technology relating to health care.
Richard A. Rudick, MD, FAAN Dr. Rudick has received personal compensation for serving as an employee of Biogen. Dr. Rudick has received stock or an ownership interest from Biogen. Dr. Rudick has received publishing royalties from a publication relating to health care.
Fred D. Lublin, MD, FAAN Dr. Lublin has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche/Genentech. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurogene. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medimmune/Viela Bio/Horizon. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Receptos/Celgene/BMS. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Labcorp. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neuralight. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Entelexo. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avotres. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Lublin has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for EMD Serono. Dr. Lublin has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for Multiple entities. Dr. Lublin has stock in Avotres. Dr. Lublin has stock in Neuralight. The institution of Dr. Lublin has received research support from Brainstorm. The institution of Dr. Lublin has received research support from biogen. The institution of Dr. Lublin has received research support from NIH.
Justin C. McArthur, MBBS, MPH, FAAN No disclosure on file
Robert J. Adams, MD No disclosure on file
Patrick D. Lyden, MD, FAAN Dr. Lyden has received personal compensation for serving as an employee of University of Southern Californiaq. Dr. Lyden has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Apex Innovations. Dr. Lyden has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Various. The institution of Dr. Lyden has received research support from NINDS.
John G. Nutt, MD, FAAN No disclosure on file
Patrick Pullicino, MD No disclosure on file
Kenneth P. Johnson, MD No disclosure on file
R E. Faught, Jr., MD, FAAN Dr. Faught has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurelis. Dr. Faught has received personal compensation in the range of $500-$4,999 for serving as a Consultant for LivaNova. Dr. Faught has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SK Life Science. Dr. Faught has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Gideon, Essary, Tardio and Carter PLC, Nashville TN TN law firm. Dr. Faught has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Friedman Dazio and Zulanas Law Firm Birmingham AL. The institution of Dr. Faught has received research support from UCB Pharma. The institution of Dr. Faught has received research support from Cognizance.
David S. Knopman, MD, FAAN Dr. Knopman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for DIAN TU study. The institution of Dr. Knopman has received research support from NIH.
Mark A. Ferrante, MD, FAAN No disclosure on file
Mark W. Mahowald, MD No disclosure on file
Patricia E. Penovich, MD, FAAN Dr. Penovich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Engage therapeutics. Dr. Penovich has received personal compensation in the range of $0-$499 for serving as a Consultant for LVIS. Dr. Penovich has received personal compensation in the range of $0-$499 for serving as a Consultant for Monteris. Dr. Penovich has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SK Therapeutics. Dr. Penovich has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurelis. Dr. Penovich has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Greenwich. Dr. Penovich has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for SK Biosciences. Dr. Penovich has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neurelis. Dr. Penovich has a non-compensated relationship as a Comittee Member with American Epilepsy Society that is relevant to AAN interests or activities.
Robert M. Herndon, MD, FAAN No disclosure on file
Douglas A. Kerr, MD, PhD Dr. Kerr has received personal compensation for serving as an employee of Dyne Therapeutics. Dr. Kerr has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for BlueRock Therapeutics. Dr. Kerr has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Trace Neuroscience. Dr. Kerr has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Spolia Therapeutics. Dr. Kerr has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for BlueRock Therapeutics. Dr. Kerr has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for AAVantgarde Therrapeutics. Dr. Kerr has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Trace Neuroscience. Dr. Kerr has or had stock in Dyne Therapeutics.
Peter A. Calabresi, MD, FAAN Dr. Calabresi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Calabresi has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Idorsia. An immediate family member of Dr. Calabresi has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MyMD. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Myelin Repair Foundation. The institution of Dr. Calabresi has received research support from Genentech. Dr. Calabresi has received publishing royalties from a publication relating to health care. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as a Study Section Member with NIH. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as a Grant reveiwer with Myelin Repair Foundation. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as a Speaker for CME with NYAS. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Academic CME.
David S. Goldstein, MD, PhD Dr. Goldstein has received publishing royalties from a publication relating to health care.
Keith Hyland, PhD No disclosure on file
Gregory Krauss, MD Dr. Krauss has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Arvelle. Dr. Krauss has received stock or an ownership interest from EpiWatch.
Douglas S. Goodin, MD No disclosure on file
Michael W. Weiner, MD Dr. Weiner has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Dolby Family Ventures. Dr. Weiner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia Pharmaceuicals. Dr. Weiner has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Acumen Pharmaceuticals. Dr. Weiner has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Guidepoibnt. Dr. Weiner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Owkin France. Dr. Weiner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Quantum Leap Health. Dr. Weiner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sai MedPartners. Dr. Weiner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MEDA Corp.. Dr. Weiner has stock in Anven. Dr. Weiner has stock in Alzeca. Dr. Weiner has stock in Alzheon, Inc.. Dr. Weiner has stock in ALZpath. The institution of Dr. Weiner has received research support from NIH/NIA; National Institutes of Health/National Institutes of Aging. Dr. Weiner has received personal compensation in the range of $500-$4,999 for serving as a Speaker/Presenter with Merck Sharp & Dohme. Dr. Weiner has received personal compensation in the range of $0-$499 for serving as a Speaker/Presenter with BrightFocus Foundation. Dr. Weiner has received personal compensation in the range of $500-$4,999 for serving as a Speaker/Presenter with Banner Health.
Anthony Traboulsee, MD Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Traboulsee has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Traboulsee has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for EMD Serono. Dr. Traboulsee has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche. The institution of Dr. Traboulsee has received research support from Roche. The institution of Dr. Traboulsee has received research support from Consortium of MS Centers. The institution of Dr. Traboulsee has received research support from MS Canada. Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving as a Workshop Chair with Consortium of MS Centers.
Senda Ajroud-Driss, MD, FAAN Dr. Ajroud-Driss has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Ajroud-Driss has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Astrazeneca. Dr. Ajroud-Driss has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Ajroud-Driss has received research support from NIH. The institution of Dr. Ajroud-Driss has received research support from University of Minesota/FDA. The institution of Dr. Ajroud-Driss has received research support from Edgewise Therapeutics. The institution of Dr. Ajroud-Driss has received research support from Biogen. The institution of Dr. Ajroud-Driss has received research support from Woolsey Pharmaceuticals. The institution of Dr. Ajroud-Driss has received research support from Uniqure Biopharma. The institution of Dr. Ajroud-Driss has received research support from Coya Therapeutics. The institution of Dr. Ajroud-Driss has received research support from Novartis. The institution of Dr. Ajroud-Driss has received research support from Alnylam pharmaceuticals. The institution of Dr. Ajroud-Driss has received research support from Healey and AMG center for ALS . The institution of Dr. Ajroud-Driss has received research support from les Turner ALS Foundation. The institution of Dr. Ajroud-Driss has received research support from Hopewell. The institution of Dr. Ajroud-Driss has received research support from Peripheral neuropathy foundation. Dr. Ajroud-Driss has received publishing royalties from a publication relating to health care.
Stefan Schwab, MD Dr. Schwab has nothing to disclose.
Alan C. Jackson, MD, FAAN No disclosure on file
Renato P. Munhoz, MD, PhD Dr. Munhoz has nothing to disclose.
Christopher J. Boes, MD, FAAN Dr. Boes has a non-compensated relationship as a Review Committee for Neurology member with ACGME that is relevant to AAN interests or activities.
Eric S. Farbman, MD, FAAN Dr. Farbman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Supernus. Dr. Farbman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva. Dr. Farbman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Acorda.
Ari Green, MD Dr. Green has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA Neurology. The institution of Dr. Green has received research support from Department of Defense. The institution of Dr. Green has received research support from Department of Defense. The institution of Dr. Green has received research support from NIH. The institution of Dr. Green has received research support from NIH / NINDS. The institution of Dr. Green has received research support from NIH / NINDS. Dr. Green has received intellectual property interests from a discovery or technology relating to health care.
Sanjib Sinha, MD No disclosure on file
Michael S. Okun, MD, FAAN Dr. Okun has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NIH. Dr. Okun has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Parkinson's Foundation. Dr. Okun has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA Neurology. Dr. Okun has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for NEJM Journal Watch. The institution of Dr. Okun has received research support from NIH. The institution of Dr. Okun has received research support from Parkinson's Foundation. The institution of Dr. Okun has received research support from Tourette Association of America. The institution of Dr. Okun has received research support from Michael J Fox. Dr. Okun has received publishing royalties from a publication relating to health care.
Michael P. McQuillen, MD, MA, FAAN No disclosure on file
Dennis W. Dickson, MD Dr. Dickson has nothing to disclose.
Paul S. Aisen, MD No disclosure on file
Clifford R. Jack, Jr., MD The institution of Dr. Jack has received research support from NIH. The institution of Dr. Jack has received research support from Alexander Family Alzheimer's Disease Research Professorship of the Mayo Clinic.
Yuen T. So, MD, PhD, FAAN No disclosure on file
Heather S. Anderson, MD, FAAN No disclosure on file
Katherine H. Noe, MD, PhD, FAAN Dr. Noe has a non-compensated relationship as a committe member, Epilepsy MOC article review pilot with American Board of Psychiatry and Neurology that is relevant to AAN interests or activities.
Jay H. Rosenberg, MD, FAAN Dr. Rosenberg has nothing to disclose.
Cynthia Bodkin, MD, FAAN Dr. Bodkin has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. The institution of Dr. Bodkin has received research support from Massachusetts General Hospital. The institution of Dr. Bodkin has received research support from Alector LL. The institution of Dr. Bodkin has received research support from Atlantic research group. The institution of Dr. Bodkin has received research support from Amicus Therapeutics. The institution of Dr. Bodkin has received research support from Alexion. The institution of Dr. Bodkin has received research support from Anelixis. The institution of Dr. Bodkin has received research support from Medicinova INC. The institution of Dr. Bodkin has received research support from Ra Pharmaceuticals Inc.
Michael Cartwright, MD Dr. Cartwright has received intellectual property interests from a discovery or technology relating to health care. Dr. Cartwright has received intellectual property interests from a discovery or technology relating to health care. Dr. Cartwright has received publishing royalties from a publication relating to health care.
Angelos Katramados, MD Dr. Katramados has nothing to disclose.
Rakefet Tsabari, MD No disclosure on file
Andrew P. Duker, MD No disclosure on file
Christopher J. Klein, MD, FAAN Dr. Klein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NMD Pharma.
Erik K. St. Louis, MD The institution of Dr. St. Louis has received research support from NIH. Dr. St. Louis has received publishing royalties from a publication relating to health care. Dr. St. Louis has received publishing royalties from a publication relating to health care.
Tanis J. Ferman, PhD Ms. Ferman has nothing to disclose.
Keith A. Josephs, Jr., MD, FAAN Dr. Josephs has nothing to disclose.
Victor M. Rivera, MD, FAAN Dr. Rivera has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for EMD Serono. Dr. Rivera has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche Laboratories. Dr. Rivera has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for LACTRIMS. Dr. Rivera has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Central American Forum on MS. Dr. Rivera has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Bracken Law Firm, El Paso, TX.
Brett C. Meyer, MD Dr. Meyer has received personal compensation in the range of $0-$499 for serving as a Consultant for Sevaro Health. An immediate family member of Dr. Meyer has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Chiesi.
Mamatha Pasnoor, MD, FAAN Dr. Pasnoor has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx BVBA. Dr. Pasnoor has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen Pharmaceutical. Dr. Pasnoor has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Pasnoor has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Pasnoor has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Grifols. Dr. Pasnoor has received personal compensation in the range of $500-$4,999 for serving as a Consultant for amgen. Dr. Pasnoor has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Regeneron. Dr. Pasnoor has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Vor Pharmaceutical.
Shalom Haggiag, MD No disclosure on file
Jorge D. Correale, MD Dr. Correale has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ROche. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Genzyme. The institution of Dr. Correale has received research support from Merck. The institution of Dr. Correale has received research support from Biogen. The institution of Dr. Correale has received research support from Novartis .
Ely S. Simon, MD No disclosure on file
Glen M. Doniger, PhD No disclosure on file
Timothy L. Vollmer, MD, FAAN The institution of Dr. Vollmer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen IDEC. The institution of Dr. Vollmer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech/Roche. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Siranax. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celgene. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Meyers Squib. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viela Bios. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. The institution of Dr. Vollmer has received research support from Rocky Mountain MS Center. The institution of Dr. Vollmer has received research support from Biogen. The institution of Dr. Vollmer has received research support from Actelion. The institution of Dr. Vollmer has received research support from Genentech/Roche. The institution of Dr. Vollmer has received research support from Anokion. The institution of Dr. Vollmer has received research support from TG Therapeutics.
Denise I. Campagnolo, MD, MS Dr. Campagnolo has received personal compensation for serving as an employee of Biogen. Dr. Campagnolo has received stock or an ownership interest from Biogen.
Anat Achiron, MD, PhD, FAAN Dr. Achiron has nothing to disclose.
No disclosure on file
Iftekhar Ahmed, MD, PC, FAAN Dr. Ahmed has nothing to disclose.
Julian Benito-Leon No disclosure on file
Brian A. Trimble, MD, MPH, FAAN No disclosure on file
Farrah J. Mateen, MD, PhD, FAAN Dr. Mateen has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Mateen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Mateen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Mateen has received research support from Genentech. The institution of Dr. Mateen has received research support from Amgen. The institution of Dr. Mateen has received research support from TG Therapeutics. Dr. Mateen has received intellectual property interests from a discovery or technology relating to health care.
Yves L. Lapierre, MD No disclosure on file
Norman Putzki, MD No disclosure on file
Volker Limmroth, MD, PhD No disclosure on file
Helene Zephir Helene Zephir has received personal compensation in the range of $0-$499 for serving as a Consultant for BIogen Idec. Helene Zephir has received personal compensation in the range of $0-$499 for serving as a Consultant for novartis. Helene Zephir has received personal compensation in the range of $0-$499 for serving as a Consultant for BMS. Helene Zephir has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion.
Jeffrey A. Allen, MD Dr. Allen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx. Dr. Allen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for csl behring. Dr. Allen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Takeda. Dr. Allen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Grifols. Dr. Allen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alnylam. Dr. Allen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Allen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astra Zeneca. Dr. Allen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Johnson and Johnson. Dr. Allen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Allen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Annexon. Dr. Allen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Immunovant. Dr. Allen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Allen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Dianthus. Dr. Allen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CSL Behring. Dr. Allen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Annexon. Dr. Allen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. Dr. Allen has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Allen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Dianthus. Dr. Allen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for CSL behring. Dr. Allen has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Takeda. Dr. Allen has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alnylam. Dr. Allen has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alexion. Dr. Allen has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Johnson and Johnson.
Lineu C. Werneck, MD No disclosure on file
Helio Afonso G. Teive, MD, PhD, FAAN Dr. Teive has nothing to disclose.
James H. Bower, MD, MSc, FAAN The institution of Dr. Bower has received research support from Abbvie.
Karen C. Albright, DO, DO, PhD, MS, MPH Dr. Albright has nothing to disclose.
Antonio Toscano, MD Dr. Toscano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme.
Elissaios Karageorgiou, MD, PhD, FAAN Dr. Karageorgiou has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Myrtelle. The institution of Dr. Karageorgiou has received research support from European Union. The institution of Dr. Karageorgiou has received research support from Alzheimer's Association.
Jean P. Azulay, MD Dr. Azulay has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for abbvie. Dr. Azulay has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier.
Dawn Bowers, PhD No disclosure on file
Roberto Ceravolo No disclosure on file
Bernard F. Michel, MD No disclosure on file
Giovanni Savettieri, MD No disclosure on file
Ola A. Selnes, PhD No disclosure on file
Luca Durelli, MD No disclosure on file
Marinella Clerico, MD Dr. Clerico has nothing to disclose.
Albert C. Ludolph, MD Dr. Ludolph has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Ludolph has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Ludolph has received personal compensation in the range of $0-$499 for serving as a Consultant for FundaMental Pharma . Dr. Ludolph has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. Dr. Ludolph has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zambon . Dr. Ludolph has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Ludolph has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche Pharma. Dr. Ludolph has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Ludolph has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alector. Dr. Ludolph has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amylyx. Dr. Ludolph has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biologix FZCo.. Dr. Ludolph has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Ludolph has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva. Dr. Ludolph has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Ludolph has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Ludolph has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Zambon.
Vittorio Martinelli Dr. Martinelli has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis, Biogen, Sanofi Genzyme, TEVA and Merck. Dr. Martinelli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck .
Giancarlo Comi, MD Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol Myers Squibb. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Aspen Healthcare. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Sanofi. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Rewind.
Tag-Eldin Sokrab, MD, PhD, FAAN Dr. Sokrab has nothing to disclose.
Amy R. Borenstein, PhD, FAAN No disclosure on file
Ralph H. Benedict, PhD Dr. Benedict has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Benedict has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Benedict has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Bristol Meyers Squibb. Dr. Benedict has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Immunic Therapeutics. Dr. Benedict has received intellectual property interests from a discovery or technology relating to health care.
Gabriella Silvestri, MD No disclosure on file
Brian Silver, MD, FAAN Dr. Silver has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Various legal firms. Dr. Silver has received intellectual property interests from a discovery or technology relating to health care. Dr. Silver has received publishing royalties from a publication relating to health care. Dr. Silver has received publishing royalties from a publication relating to health care. Dr. Silver has received publishing royalties from a publication relating to health care. Dr. Silver has received personal compensation in the range of $500-$4,999 for serving as a Consultant with Women's Health Initiative. Dr. Silver has received personal compensation in the range of $500-$4,999 for serving as a Consultant with Best Doctors, Inc./Teladoc, Inc.. Dr. Silver has a non-compensated relationship as a Consultant with ABPN that is relevant to AAN interests or activities. Dr. Silver has a non-compensated relationship as a Member, Regional Board of Directors with American Heart Association that is relevant to AAN interests or activities.
Ramon L. Rodriguez Cruz, MD, FAAN The institution of Dr. Rodriguez Cruz has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbvie. The institution of Dr. Rodriguez Cruz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Supernus . The institution of Dr. Rodriguez Cruz has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurocrine. The institution of Dr. Rodriguez Cruz has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Boston Scientific. The institution of Dr. Rodriguez Cruz has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbott. The institution of Dr. Rodriguez Cruz has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Acorda. The institution of Dr. Rodriguez Cruz has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Teva. The institution of Dr. Rodriguez Cruz has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Kyoway Kirin. The institution of Dr. Rodriguez Cruz has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie. The institution of Dr. Rodriguez Cruz has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Amneal. The institution of Dr. Rodriguez Cruz has received research support from Cerevance. The institution of Dr. Rodriguez Cruz has received research support from Neuraly. The institution of Dr. Rodriguez Cruz has received research support from Amneal. The institution of Dr. Rodriguez Cruz has received research support from Teva. The institution of Dr. Rodriguez Cruz has received research support from Neurocrine. Dr. Rodriguez Cruz has received publishing royalties from a publication relating to health care.
Michael Hutchinson, MD Dr. Hutchinson has nothing to disclose.
Douglas R. Jeffery, MD, PhD No disclosure on file
Arnaud Lacour No disclosure on file
Andreas Konieczny No disclosure on file
Dawn W. Langdon, PhD Prof. Langdon has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck. Prof. Langdon has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. The institution of Prof. Langdon has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celgene. Prof. Langdon has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Celgene. Prof. Langdon has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Prof. Langdon has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer. The institution of Prof. Langdon has received research support from Merck. The institution of Prof. Langdon has received research support from Novartis. The institution of Prof. Langdon has received research support from MS Society (UK). The institution of Prof. Langdon has received research support from Multiple Sclerosis Trust (UK).
George C. Ebers, MD No disclosure on file
Kelly D. Foote, MD Kelly D. Foote, MD has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Axio/Neurocrine Biosciences.
Abu Nasar No disclosure on file
Joon-Shik Moon, MD Dr. Moon has nothing to disclose.
Juan J. Figueroa, MD No disclosure on file
Benjamin M. Greenberg, MD, FAAN Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Greenberg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Greenberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen. Dr. Greenberg has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Sanofi/Genzyme. Dr. Greenberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech/Roche. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Signant. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for IQVIA. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sandoz. Dr. Greenberg has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Clene. Dr. Greenberg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG Therapeutics. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for IQVIA. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abcuro. Dr. Greenberg has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Siegel Rare Neuroimmune Association. Dr. Greenberg has or had stock in GenrAb.Dr. Greenberg has or had stock in Clene.Dr. Greenberg has received intellectual property interests from a discovery or technology relating to health care. Dr. Greenberg has received publishing royalties from a publication relating to health care.
Didier Ferriby, MD No disclosure on file
Olivier Outteryck Olivier Outteryck has nothing to disclose.
Gary R. Cutter, PhD Dr. Cutter has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for onsulting or Advisory Boards: Alexion, Antisense Therapeutics/Percheron, Avotres, Biogen, Clene Nanomedicine, Clinical Trial Solutions LLC, Endra Life Sciences, Cognito Therapeutics, Genzyme, Genentech, Immunic, Klein-Buendel Incorporated, Kyverna Therapeutics, Inc. , Linical, Merck/Serono, Noema, Neurogenesis, Perception Neurosciences, Protalix Biotherapeutics, Regeneron, Revelstone Consulting, Roche, SAB Biotherapeutics, Sapience Therapeutics, Scott&Scott LLP, Tenmile.. Dr. Cutter has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Data and Safety Monitoring Boards: Applied Therapeutics, AI therapeutics, AMO Pharma, Argenx, Astra-Zeneca, Avexis Pharmaceuticals, Bristol Meyers Squibb, CSL Behring, Cynata Therapeutics, DiamedicaTherapeutics, Horizon Pharmaceuticals, Immunic, Inhibrix, Karuna Therapeutics, Kezar Life Sciences, Medtronic, Merck, Meiji Seika Pharma, Mitsubishi Tanabe Pharma Holdings, Prothena Biosciences, Novartis, Pipeline Therapeutics (Contineum), Regeneron, Sanofi-Aventis, Teva Pharmaceuticals, United BioSource LLC, University of Texas Southwestern.. Dr. Cutter has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JASN.
Ruth-Ann Marrie, MD, PhD The institution of Dr. Marrie has received research support from CIHR. The institution of Dr. Marrie has received research support from MS Canada. The institution of Dr. Marrie has received research support from National MS Society. The institution of Dr. Marrie has received research support from Crohn's and Colitis Canada. The institution of Dr. Marrie has received research support from US Department of Defense. The institution of Dr. Marrie has received research support from The Arthritis Society. The institution of Dr. Marrie has received research support from CMSC.
Tanya Stojkovic Tanya Stojkovic has nothing to disclose.
M. Antonietta Volonte, MD Dr. Volonte has nothing to disclose.
Oezguer Yaldizli, MD Dr. Yaldizli has nothing to disclose.
Robert Cote, MD No disclosure on file
Robert G. Smith, MD, PhD, FAAN Dr. Smith has nothing to disclose.
Vida Demarin, MD, PhD, FAAN No disclosure on file
Yonas E. Geda, MD The institution of Dr. Geda has received research support from NIH. Dr. Geda has received intellectual property interests from a discovery or technology relating to health care.
P. James B. Dyck, MD, FAAN Dr. Dyck has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Akcea/Ionis.
Nizar Souayah, MD, FAAN Dr. Souayah has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Takeda. Dr. Souayah has received publishing royalties from a publication relating to health care.
Sami L. Khella, MD, FAAN Dr. Khella has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ionis. Dr. Khella has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ionis. Dr. Khella has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Khella has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam. Dr. Khella has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eidos.
Robert J. Ivnik, PhD No disclosure on file
Glenn E. Smith, MD, PhD No disclosure on file
Maria M. Shiung, BA No disclosure on file
Afshin A. Divani, PhD The institution of Dr. Divani has received research support from Department of Defense.
Edgardo Cristiano, MD Dr. Cristiano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Cristiano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Cristiano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genzyme. Dr. Cristiano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Cristiano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck.
Jacqueline Palace Dr. Palace has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck Serono, Medimmune, Argenx, Janssen, AMgen, UCB, Roche, Novartis, Amplo, Alexion, . Dr. Palace has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx, Sanofi. Dr. Palace has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Roche, UCB, Alexion, Amgen. Dr. Palace has or had stock in Astra Zenica. The institution of Dr. Palace has received research support from Roche, AMPLO, Alexion, UCB,. argenx, amgen. Dr. Palace has received intellectual property interests from a discovery or technology relating to health care.
Frederick E. Munschauer III, MD, FAAN Dr. Munschauer has received personal compensation for serving as an employee of Emalex Biosciences. Dr. Munschauer has stock in Emalex Biosciences.
Bianca Weinstock-Guttman, MD Dr. Weinstock-Guttman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Weinstock-Guttman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Weinstock-Guttman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis . Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme &Sanofi. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen . Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Weinstock-Guttman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Weinstock-Guttman has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen. Dr. Weinstock-Guttman has received personal compensation in the range of $0-$499 for serving as a Reviewer with NIH.
Michele K. York, PhD, ABPP-CN Dr. York has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for RAD-PD. The institution of Dr. York has received research support from Michael J. Fox Foundation. The institution of Dr. York has received research support from NIH. The institution of Dr. York has received research support from Takeda.
Eugene C. Lai, MD, PhD, FAAN Dr. Lai has received publishing royalties from a publication relating to health care.
Stephen S. Kirzinger, MD, FAAN No disclosure on file
Michael R. Jacoby, MD Dr. Jacoby has nothing to disclose.
Panayiotis Mitsias, MD The institution of Dr. Mitsias has received research support from European Union.
Paul J. Massman, PhD No disclosure on file
Karine Viala No disclosure on file
Thierry Maisonobe No disclosure on file
Pierre Bouche, MD No disclosure on file
Laura Herbelin No disclosure on file
Jose R. Romero, MD The institution of Dr. Romero has received research support from NIH/NIA.
Jacqueline Channon-Smith No disclosure on file
David Grabli No disclosure on file
Honglan Li, PhD Dr. Li has received personal compensation for serving as an employee of Novo Nordisk Inc. Dr. Li has stock in Novo Nordisk Inc.
Rosario Maria S. Riel-Romero, MD, FAAN Dr. Riel-Romero has stock in Biointech. Dr. Riel-Romero has stock in Intuitive Surgical. Dr. Riel-Romero has stock in CRISPR. Dr. Riel-Romero has received personal compensation in the range of $100,000-$499,999 for serving as a Professor with LSU. An immediate family member of Dr. Riel-Romero has received personal compensation in the range of $100,000-$499,999 for serving as a Surgeon with VA.
Anthony Reder, MD Dr. Reder has nothing to disclose.
Diana Dimitrova, PhD No disclosure on file
Byung-Jo Kim No disclosure on file
Carlos A. Pardo-Villamizar, MD The institution of Dr. Pardo-Villamizar has received research support from National Institutes of Health. The institution of Dr. Pardo-Villamizar has received research support from Bart McLean Fund for Neuroimmunology Research .
Bruno Brochet, MD, FEAN Prof. Brochet has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Prof. Brochet has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for celgene. Prof. Brochet has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for jansen. Prof. Brochet has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for biogen. Prof. Brochet has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for novartis. Prof. Brochet has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for merck. Prof. Brochet has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for biogen. Prof. Brochet has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for celgene.
Martin Nevrly, MD No disclosure on file
Seung-Han Lee, MD, PhD Dr. Lee has nothing to disclose.
Tatiana Witjas No disclosure on file
Matthew Senjem Matthew Senjem has received stock or an ownership interest from Align Technology, Inc.. Matthew Senjem has received stock or an ownership interest from Inovio Biomedical Corp.. Matthew Senjem has received stock or an ownership interest from Johnson & Johnson. Matthew Senjem has received stock or an ownership interest from Mesa Laboratories, Inc.. Matthew Senjem has received stock or an ownership interest from Nvidia Inc.. Matthew Senjem has received stock or an ownership interest from LHC Group, Inc.. Matthew Senjem has received stock or an ownership interest from Natus Medical Incorporated. Matthew Senjem has received stock or an ownership interest from Varex Imaging Corporation. Matthew Senjem has received personal compensation in the range of $100,000-$499,999 for serving as a IT Technical Specialist II with Mayo Clinic.
Peter Rieckmann, MD, FAAN No disclosure on file
Wendy Frye No disclosure on file
Lindsey E. Kirsch Darrow No disclosure on file
Stephen Weigand Stephen Weigand has nothing to disclose.
Victor Biton, MD Dr. Biton has nothing to disclose.
Peter C. O'Brien, PhD No disclosure on file
Nuran Dilek Nuran Dilek has nothing to disclose.
Stephanie Cantiniaux No disclosure on file
Madhuri Behari, MD No disclosure on file
Daniel L. Labovitz, MD An immediate family member of Dr. Labovitz has received personal compensation for serving as an employee of Herrick Feinstein.
Osvaldo J. Nascimento, MD, PhD, FAAN Dr. Nascimento has nothing to disclose.
Peter J. Dyck, MD, FAAN Dr. Dyck has nothing to disclose.
Teresa Frohman, PA No disclosure on file
Mustafa S. Siddiqui, MD, FAAN Dr. Siddiqui has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Boston Scientific Neuromodulation. Dr. Siddiqui has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic. The institution of Dr. Siddiqui has received research support from Boston Scientific Neuromodulation. The institution of Dr. Siddiqui has received research support from Abbvie. The institution of Dr. Siddiqui has received research support from National Institute of Health .
Mathias Maurer, MD No disclosure on file
Victoria Lawson, MD, FAAN Dr. Lawson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi.
Harrison C. Walker III, MD Dr. Walker has nothing to disclose.
Barton Guthrie No disclosure on file
Jennifer Whitwell, PhD The institution of Dr. Whitwell has received research support from NIH.
Russell L. Chin, MD No disclosure on file
Mohammed Rehman, DO Dr. Rehman has nothing to disclose.
Souvik Sen, MD, MS Dr. Sen has nothing to disclose.
Alexander W. Dromerick, MD No disclosure on file
Rebecca M. Pruss, PhD No disclosure on file
Francois Viallet, MD No disclosure on file
Marco D'Amelio, MD No disclosure on file
Paolo Ragonese No disclosure on file
Maria Tintore-Subirana, MD No disclosure on file
Barbara E. Tettenborn, MD No disclosure on file
Ricardo F. Allegri, MD, PhD, FAAN Dr. Allegri has nothing to disclose.
Cecilia Serrano No disclosure on file
Ramesh Madhavan, MD, FAAN Dr. Madhavan has received stock or an ownership interest from TiaTech USA and TiaTech India. Dr. Madhavan has received intellectual property interests from a discovery or technology relating to health care.
Sue M. Lai, PhD No disclosure on file
Liliana B. Patrucco, MD Dr. Patrucco has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Dr. Patrucco has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Patrucco has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Novartis. Dr. Patrucco has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Biogen.
Yousef Mohammad, MD No disclosure on file
Carlo Pozzilli Carlo Pozzilli has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Carlo Pozzilli has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Carlo Pozzilli has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Carlo Pozzilli has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion.
Yaakov Stern, PhD Dr. Stern has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Stern has received intellectual property interests from a discovery or technology relating to health care. Dr. Stern has received publishing royalties from a publication relating to health care.
Martin Brodie Martin Brodie has nothing to disclose.
Howard P. Goodkin, MD, PhD, FAAN Dr. Goodkin has received research support from NIH. Dr. Goodkin has received publishing royalties from a publication relating to health care.
Effie Kaltsas No disclosure on file
Jyh-Gong G. Hou, MD, PhD, FAAN No disclosure on file
Holly B. Posner, MD No disclosure on file
Steven Ferris No disclosure on file
Deanna Saylor, MD, MHS, FAAN Dr. Saylor has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for 好色先生. The institution of Dr. Saylor has received research support from National Institutes of Health. The institution of Dr. Saylor has received research support from 好色先生. Dr. Saylor has a non-compensated relationship as a Member of multiple committees and task forces focused on improving access to MS medications to people across the world with Multiple Sclerosis International Federation that is relevant to AAN interests or activities. Dr. Saylor has a non-compensated relationship as a Member of the Neurology and COVID19 committee with World Health Organization that is relevant to AAN interests or activities. Dr. Saylor has a non-compensated relationship as a Member of the International Outreach Committee, Junior and Early Career Membership Committee, and 好色先生al Innovation Commitees with American Neurological Association that is relevant to AAN interests or activities.
Robert A. Bermel, MD, FAAN Dr. Bermel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi/Genzyme. Dr. Bermel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech/Roche. Dr. Bermel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Bermel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for TG Therapeutics. The institution of Dr. Bermel has received research support from Biogen. The institution of Dr. Bermel has received research support from Roche. The institution of Dr. Bermel has received research support from Novartis. Dr. Bermel has received intellectual property interests from a discovery or technology relating to health care.
Richard C. Burgess, MD, PhD Dr. Burgess has nothing to disclose.
Carolin Miltenburger, PhD No disclosure on file
Warren W. Barker, MA No disclosure on file
John A. Lucas John A. Lucas has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for American Board of Clinical Neuropsychology.
Akram Shhadeh, MD, MBA No disclosure on file
Ranjan Duara, MD Dr. Duara has nothing to disclose.
Daniel Reich, MD, PhD Dr. Reich has received research support from NIH. The institution of Dr. Reich has received research support from Adelson Medical Research Foundation. The institution of Dr. Reich has received research support from Sanofi. The institution of Dr. Reich has received research support from Abata Therapeutics. The institution of Dr. Reich has received research support from National Multiple Sclerosis Society. The institution of Dr. Reich has received research support from Cure Alzheimer's Fund. Dr. Reich has received intellectual property interests from a discovery or technology relating to health care. Dr. Reich has received personal compensation in the range of $5,000-$9,999 for serving as a CME Faculty with Integrity. Dr. Reich has received personal compensation in the range of $500-$4,999 for serving as a CME Faculty with Letters and Sciences. Dr. Reich has received personal compensation in the range of $500-$4,999 for serving as a CME Faculty with Academic CME. Dr. Reich has a non-compensated relationship as a Advisor with Sanofi that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Board of Directors with ACTRIMS that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Abata Therapeutics that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with University of Basel RC2NB that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Multiple Sclerosis Society of Canada that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Tuscan Doctorate in Neuroscience that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Editorial Board with Multiple Sclerosis Journal that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator, Advisor with Hyperfine that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator with Imaginab that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator with Annexon that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator, Advisor with Philips that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator with Siemens that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Calico Life Sciences that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Cognito Therapeutics that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Sudo that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Allumis that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with BioCentury that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator with Regeneron that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator with Eli Lilly that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with SetPoint that is relevant to AAN interests or activities.
Seth A. Smith, PhD Dr. Smith has nothing to disclose.
Sungho K. Cho, MD Dr. Cho has nothing to disclose.
Sean I. Savitz, MD Dr. Savitz has nothing to disclose.
Tobias Loddenkemper, MD, FAAN No disclosure on file
Peter Siao Tick Chong, MD No disclosure on file
James A. Mortimer, PhD, FAAN No disclosure on file
Radhika Srinivasan, PhD No disclosure on file
Christopher Skidmore, MD Dr. Skidmore has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for SALTZ MONGELUZZI BENDESKY LLC. The institution of Dr. Skidmore has received research support from Neuropace. The institution of Dr. Skidmore has received research support from Jazz Pharmaceuticals. The institution of Dr. Skidmore has received research support from Rapport Therapeutics.
Scott Mintzer, MD No disclosure on file
Michael Dobbs, MD Dr. Dobbs has received publishing royalties from a publication relating to health care.
Lyell K. Jones, MD, FAAN Dr. Jones has received personal compensation in the range of $100,000-$499,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for 好色先生. Dr. Jones has received publishing royalties from a publication relating to health care. Dr. Jones has received personal compensation in the range of $10,000-$49,999 for serving as a President-Elect with 好色先生. Dr. Jones has a non-compensated relationship as a member of the AAN Board of Directors with AAN that is relevant to AAN interests or activities. Dr. Jones has a non-compensated relationship as a Chair of the Mayo Clinic ACO Board of Directors with Mayo Clinic that is relevant to AAN interests or activities.
Gustavo J. Rodriguez, MD Dr. Rodriguez has nothing to disclose.
Dennis R. Mosier, MD, PhD No disclosure on file
Timothee Lenglet, Jr., MD No disclosure on file
Alexandre Eusebio, MD No disclosure on file
Dorothee E. Chabas-Chanezon, MD, PhD No disclosure on file
Georgia D. Montouris, MD No disclosure on file
Robert J. Schwartzman, MD No disclosure on file
David E. Newman-Toker, MD, PhD, FAAN The institution of Dr. Newman-Toker has received research support from NIH, AHRQ, AHA, Moore Foundation. Dr. Newman-Toker has received intellectual property interests from a discovery or technology relating to health care.
Jessica Carpenter, MD Dr. Carpenter has nothing to disclose.
Steven L. Weinstein, MD No disclosure on file
Janice Y. Maldonado, MD The institution of Dr. Maldonado has received research support from Genentech.
Mark Dolev Dolgopiat, MD No disclosure on file
Cory C. Toth, MD No disclosure on file
Wael N. Haidar, MD No disclosure on file
J. Douglas Miles, MD, PhD, FAAN Dr. Miles has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx US, Inc.. Dr. Miles has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB, Inc.. Dr. Miles has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion Pharmaceuticals, Inc. . Dr. Miles has received research support from HMSA Center of Learning Innovation. Dr. Miles has received publishing royalties from a publication relating to health care.
John F. Kramer, BA, PA-C Mr. Kramer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Mr. Kramer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Mr. Kramer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Mr. Kramer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Serono. Mr. Kramer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Myers Squibb. Mr. Kramer has received research support from Biogen. Mr. Kramer has received research support from Genentech.
Amy Pace, ScD No disclosure on file
Amie W. Hsia, MD The institution of Dr. Hsia has received research support from NIH/NINDS.
Robert Hyde, PhD Dr. Hyde has received personal compensation for serving as an employee of Biogen International GmbH . Dr. Hyde has received stock or an ownership interest from Biogen .
Bruce L. Hughes, MD, FAAN No disclosure on file
Sheryl Martin-Schild, MD, PhD, FAAN No disclosure on file
Jonathan B. Strober, MD Dr. Strober has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Strober has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Scholar Rock. Dr. Strober has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenyx. Dr. Strober has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Strober has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Pediatric Neurology. Dr. Strober has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Many Law Firms. The institution of Dr. Strober has received research support from Anonymous. The institution of Dr. Strober has received research support from PTC. The institution of Dr. Strober has received research support from Fibrogen. The institution of Dr. Strober has received research support from Jansen. The institution of Dr. Strober has received research support from Biohaven.
Mark Gudesblatt, MD The institution of Dr. Gudesblatt has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for genentech. The institution of Dr. Gudesblatt has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen.
Latha Ganti, MD, MS, MBA, FACEP, FAAN Dr. Ganti has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. Dr. Ganti has received publishing royalties from a publication relating to health care.
Neil Miller No disclosure on file
Darin T. Okuda, MD, FAAN Dr. Okuda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Okuda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cortechs AI. Dr. Okuda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Okuda has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Okuda has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Okuda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octave Bioscience. Dr. Okuda has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Pfizer. Dr. Okuda has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Zenas BioPharma. The institution of Dr. Okuda has received research support from Novartis. The institution of Dr. Okuda has received research support from Alexion. Dr. Okuda has received intellectual property interests from a discovery or technology relating to health care.
Helen Tremlett, PhD, BPharm Dr. Tremlett has nothing to disclose.
Bhupendra O. Khatri, MD, FAAN Dr. Khatri has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Alexion. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Khatri has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for ER Squibb (Bristol Myer Squibb). Dr. Khatri has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizone. Dr. Khatri has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Khatri has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for TG Therapeutics. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genzyne. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genzyme. Dr. Khatri has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Alexion. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Seronoe. Dr. Khatri has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for E.R. Squibb. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Horizon. Dr. Khatri has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Janssen. Dr. Khatri has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for TG Therapeutic. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genzyme. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Khatri has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Argenx US. The institution of Dr. Khatri has received research support from Biogen.
Gerald P. Novak, MD No disclosure on file
Michael I. Shevell, MD, FAAN Dr. Shevell has nothing to disclose.
Joel M. Trugman, MD, FAAN Dr. Trugman has received personal compensation for serving as an employee of AbbVie. Dr. Trugman has stock in AbbVie.
Paul C. Van Ness, MD, FAAN No disclosure on file
Giuseppe Salemi, MD No disclosure on file
Man Mohan Mehndiratta, MD, MBBS, FAAN Dr. Mehndiratta has nothing to disclose.
Mohammad Wasay, MBBS, FAAN Dr. Wasay has nothing to disclose.
Anne Dunne, RN, MBA No disclosure on file
Felix Rosenow, MD No disclosure on file
Subhash Kaul, MD, DM, FAAN No disclosure on file
Paolo Del Dotto, MD No disclosure on file
Inge J. Loy-English, MD No disclosure on file
Johannes Jakobsen, MD, DMSci The institution of Dr. Jakobsen has received research support from TAKEDA. Dr. Jakobsen has received publishing royalties from a publication relating to health care. Dr. Jakobsen has received personal compensation in the range of $5,000-$9,999 for serving as a Advisor with Danish Medicine Counsil.
Jean C. Ouallet Jean C. Ouallet has nothing to disclose.
Scott Grossman No disclosure on file
Pamela Doty, PhD No disclosure on file
Christian Grommes, MD Dr. Grommes has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ono. Dr. Grommes has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BTG. Dr. Grommes has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Grommes has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Curis. Dr. Grommes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Ono.
Diana Richardson, MD No disclosure on file
Antoine Gueguen, MD An immediate family member of Dr. Gueguen has received personal compensation for serving as an employee of ABBVIE. Dr. Gueguen has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for ALEXION. Dr. Gueguen has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Jonhson&Jonhson. Dr. Gueguen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Johnson&Johnson. The institution of Dr. Gueguen has received research support from BrainEver. The institution of Dr. Gueguen has received research support from Pixyl. The institution of Dr. Gueguen has received research support from Kalsiom. The institution of Dr. Gueguen has received research support from Ministére de la Santé, France.
Maria Diaz No disclosure on file
Serkan Ozakbas, MD Dr. Ozakbas has nothing to disclose.
M. Fernanda Bellolio, MD No disclosure on file
Melissa Bonnet No disclosure on file
Barbara Bumstead, NP Ms. Bumstead has nothing to disclose.
Amanda Castle No disclosure on file
Mary Dukic, RN No disclosure on file
Monica Falautano Monica Falautano has nothing to disclose.
Eliza M. Gordon-Lipkin, MD No disclosure on file
Ronald Graf No disclosure on file
Maria T. Greig Custo No disclosure on file
Florian Hatz, MD No disclosure on file
Mohammad Ikram The institution of Mohammad Ikram has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BioGen Inc.
David Irwin, MD The institution of Dr. Irwin has received research support from NIH. The institution of Dr. Irwin has received research support from Prevail. The institution of Dr. Irwin has received research support from Passage Bio. The institution of Dr. Irwin has received research support from Alector. The institution of Dr. Irwin has received research support from Transposon. The institution of Dr. Irwin has received research support from Denali. The institution of Dr. Irwin has received research support from Cervo Med.
Melissa Murray, PhD Dr. Murray has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Avid Radiopharmaceuticals. The institution of Dr. Murray has received research support from National Institute on Aging. The institution of Dr. Murray has received research support from Alzheimer's Association. The institution of Dr. Murray has received research support from Chan Zuckerberg Initiative.
Bindu Menon, MD, MBBS, FAAN Dr. Menon has nothing to disclose.
Dulka Manawadu, MD No disclosure on file
Rema Raman, PhD No disclosure on file
Vanessa Marques No disclosure on file
Wilson Marques, Jr., MD Dr. Marques has nothing to disclose.
Louise R. Rodino-Klapac Ms. Rodino-Klapac has received personal compensation for serving as an employee of Sarepta Therapeutics, Inc.. Ms. Rodino-Klapac has received stock or an ownership interest from Sarepta Therapeutics. Ms. Rodino-Klapac has received intellectual property interests from a discovery or technology relating to health care.
Andrea L. Rosso, MPH No disclosure on file
I. Jon Russell No disclosure on file
Lonni Schultz, PhD Dr. Schultz has nothing to disclose.
Jeffrey Tobias, MD No disclosure on file
Michael H. Rosenbloom, MD, FAAN Dr. Rosenbloom has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Esai. Dr. Rosenbloom has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Eisai. Dr. Rosenbloom has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Lilly. Dr. Rosenbloom has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Johnson and Johnson. Dr. Rosenbloom has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Medscape.
John Ratchford, MD Dr. Ratchford has received personal compensation for serving as an employee of Genentech. Dr. Ratchford has stock in F. Hoffman La-Roche.
Bryan T. Klassen, MD The institution of Dr. Klassen has received research support from Insightec.
Kamakshi Lakshminarayan, MD, PhD Dr. Lakshminarayan has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ABBOTT Labs. The institution of Dr. Lakshminarayan has received research support from NIH.
Lucia Moiola, MD, PhD Dr. Moiola has nothing to disclose.
Mathias Maeurer, MD No disclosure on file
Renee D. Van Stavern, MD, FAAN An immediate family member of Dr. Van Stavern has received intellectual property interests from a publication relating to health care.
Arthur R. Dick, MD No disclosure on file
Karola Beckmann No disclosure on file
Mazen M. Dimachkie, MD, FAAN Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Octapharma. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ArgenX. Dr. Dimachkie has received personal compensation in the range of $0-$499 for serving as a Consultant for Catalyst. Dr. Dimachkie has received personal compensation in the range of $0-$499 for serving as a Consultant for Takeda. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medlink. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSL Behring. Dr. Dimachkie has received personal compensation in the range of $0-$499 for serving as a Consultant for Astellas. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Janssen. Dr. Dimachkie has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Dianthus. Dr. Dimachkie has received personal compensation in the range of $0-$499 for serving as a Consultant for TACT / Treat NMD. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cabaletta Bio. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clinical Neurological Society of America, Inc . Dr. Dimachkie has received personal compensation in the range of $0-$499 for serving as a Consultant for Ig Society, Inc. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abcuro. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amicus. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizon/Immunovant. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ipsen. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nuvig. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for 好色先生 (AAN). Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for American Association of Neuromuscular and Electrodiagnostic Medicine (AANEM). Dr. Dimachkie has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Annexon Biosciences. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AstraZeneca. Dr. Dimachkie has received personal compensation in the range of $0-$499 for serving as a Consultant for Candid Therapeutics. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Creyon Bio, Inc.. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nuvig Therapeutics. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB Biopharma. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vertex Pharmaceuticals. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Fortrea. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kriya Therapeutics. The institution of Dr. Dimachkie has received research support from NIH. The institution of Dr. Dimachkie has received research support from The Myositis Association. The institution of Dr. Dimachkie has received research support from Biosensics. Dr. Dimachkie has received intellectual property interests from a discovery or technology relating to health care. Dr. Dimachkie has received intellectual property interests from a discovery or technology relating to health care. Dr. Dimachkie has received intellectual property interests from a discovery or technology relating to health care. Dr. Dimachkie has received publishing royalties from a publication relating to health care. Dr. Dimachkie has received publishing royalties from a publication relating to health care.
Dennis Meletiche No disclosure on file
Fatema J. Serajee, MBBS Dr. Serajee has nothing to disclose.
Ahm M. Huq, MBBS, PhD Dr. Huq has nothing to disclose.
Brandon R. Barton, MD, FAAN Dr. Barton has nothing to disclose.
Sheng-Han Kuo, MD, FAAN Dr. Kuo has nothing to disclose.
Jennifer R. Molano, MD, FAAN Dr. Molano has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Massachusetts Medical Society . The institution of Dr. Molano has received research support from National Institutes of Health.
Maja Tippmann-Peikert, MD Dr. Tippmann-Peikert has nothing to disclose.
Siong-Chi Lin, MD No disclosure on file
David S. Tabby, DO, FAAN No disclosure on file
Huana C. Marin, MD No disclosure on file
Donald H. Todman, MD, MBBS, FAAN No disclosure on file
Valeria Paula Fazan, MD, PhD No disclosure on file
Andrew Russman, DO, FAAN Dr. Russman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Boston Scientific Corporation. Dr. Russman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic. Dr. Russman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech.
Miho Murata No disclosure on file
Marta Radaelli Marta Radaelli has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck Serono. Marta Radaelli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Marta Radaelli has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Marta Radaelli has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Sanofi-Genzyme.
Lana Chahine, MD, FAAN Dr. Chahine has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gray Matters Technology. The institution of Dr. Chahine has received research support from UPMC. The institution of Dr. Chahine has received research support from MJFF. The institution of Dr. Chahine has received research support from Denali/Biogen. Dr. Chahine has received publishing royalties from a publication relating to health care.
Petra Schicklmaier, PhD No disclosure on file
Gabriele Niemczyk, MD No disclosure on file
Galeno Rojas, MD No disclosure on file
Sandro Iannaccone No disclosure on file
Omar Garcia No disclosure on file
Judith Stephenson No disclosure on file
Elizabeth Potter, DO, PhD No disclosure on file
Cristina Duran No disclosure on file
Adriana M. Strutt, PhD No disclosure on file
Stefano Tamburin No disclosure on file
Sandra Morovic, MD, PhD No disclosure on file
Amy Conger No disclosure on file
Juan Ignacio Rojas, MD Dr. Rojas has nothing to disclose.
Esther Bisker No disclosure on file
Helard A. Miranda, MD No disclosure on file
Fredy J. Revilla, MD, FAAN Dr. Revilla has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TEVA . Dr. Revilla has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TEVA .
Kimberley M. Thacker, MD No disclosure on file
Veronica Sesi, DO No disclosure on file
Girish S. Hiremath, MD No disclosure on file
Mark A. Granner, MD No disclosure on file
Jeremiah Aakre, MPH Mr. Aakre has nothing to disclose.
Salim Abboud No disclosure on file
Arsalan Ahmad, MD Dr. Ahmad has received stock or an ownership interest from Shifa International Hospitals Limited (Current employer).
Fusun Alehan, MD No disclosure on file
Amza Ali, MD, FRCP, FAAN No disclosure on file
Mhd R. Alkawadri, MD Dr. Alkawadri has nothing to disclose.
Teresa Ambrosio No disclosure on file
Basel Assaad, MD No disclosure on file
Steve Balsis No disclosure on file
Emmanuel J. Bartholome Emmanuel J. Bartholome has received personal compensation for serving as an employee of Indivi AG. Emmanuel J. Bartholome has received personal compensation for serving as an employee of Biogen.
David Bates No disclosure on file
Gary Bennett, MD No disclosure on file
Nisha S. Bhatia, MD No disclosure on file
Pratik D. Bhattacharya, MD, MPH Dr. Bhattacharya has a non-compensated relationship as a Research Advisor with Defeat MSA Alliance 501 (c) (3) that is relevant to AAN interests or activities.
Kathryn Bronstein No disclosure on file
Joerg-Peter Bugge, PhD No disclosure on file
Adam R. Burkey, MD Dr. Burkey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Nevro Corporation.
Joseph Cappelleri Joseph Cappelleri has received personal compensation for serving as an employee of Pfizer Inc. Joseph Cappelleri has stock in Pfizer Inc.
Pablo R. Castillo, MD, FAAN Dr. Castillo has nothing to disclose.
Arun Chandok, MD Dr. Chandok has nothing to disclose.
Andrew L. Chesson, Jr., MD, FAAN No disclosure on file
Richard Choi, DO No disclosure on file
Devon Conway, MD Dr. Conway has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Conway has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Conway has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Conway has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen. Dr. Conway has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Conway has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Conway has received research support from Novartis. The institution of Dr. Conway has received research support from BMS. The institution of Dr. Conway has received research support from Biogen.
Alper I. Dai, MD No disclosure on file
Kristina Darnauer No disclosure on file
Teresa M. DeAngelis, MD No disclosure on file
Ivan Diamond, MD, PhD, FAAN No disclosure on file
Megan Donohue, MD Dr. Donohue has nothing to disclose.
Anh Duong, PhD No disclosure on file
Robert H. Dworkin, PhD Robert H. Dworkin, PhD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia, Akigai, Allay, AM-Pharma, Analgesic Solutions, Beckley, Biogen, Biosplice, Bsense, Cardialen, Chiesi, Clexio, Collegium, CombiGene, Confo, Contineum, Eccogene, Editas, Eli Lilly, Emmes, Endo, Epizon, Exicure, GlaxoSmithKline, Glenmark, Gloriana, JucaBio, Kriya, Mainstay, Merck, Mind Medicine, NeuroBo, Noema, OliPass, Orion, Oxford Cannabinoid Technologies, Pfizer, Q-State, Regenacy, Rho, Sangamo, Semnur, SIMR Biotech, Sinfonia, SK Biopharmaceuticals, Sparian, SPM Therapeutics, SPRIM Health, Tiefenbacher, Validae, Vertex, Viscera, and WCG.
Ugo Ecari, MD No disclosure on file
Eric Ehrensperger, MD No disclosure on file
Siegward M. Elsas, MD No disclosure on file
Mila Etropolski, MD No disclosure on file
Wayne W. Feng, MD, FAAN Dr. Feng has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Namsa. The institution of Dr. Feng has received research support from NIH. The institution of Dr. Feng has received research support from American heart association . The institution of Dr. Feng has received research support from Ipsen.
Maria C. Fernandez, MD Dr. Fernandez has nothing to disclose.
Madeline C. Fields, MD Dr. Fields has nothing to disclose.
Contessa Fincher No disclosure on file
John F. Foley, MD, FAAN The institution of Dr. Foley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octave. Dr. Foley has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. The institution of Dr. Foley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics . The institution of Dr. Foley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics. The institution of Dr. Foley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz. Dr. Foley has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Foley has stock in InterPRO Bioscience. The institution of Dr. Foley has received research support from Biogen. The institution of Dr. Foley has received research support from Novartis. The institution of Dr. Foley has received research support from Octave. The institution of Dr. Foley has received research support from Genentech. The institution of Dr. Foley has received research support from Imstem. The institution of Dr. Foley has received research support from Aegir.
Pamela Foulds, MD No disclosure on file
Ada Francia, MD No disclosure on file
Kimberly Fraser No disclosure on file
Robert N. Gan, MD No disclosure on file
Serge G. Gauthier, MD Dr. Gauthier has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TauRx . Dr. Gauthier has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly Canada . Dr. Gauthier has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai . Dr. Gauthier has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ENIGMA USA. Dr. Gauthier has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AmyriAD. Dr. Gauthier has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medesis. Dr. Gauthier has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Alzheon. Dr. Gauthier has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Karuna. Dr. Gauthier has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Otsuka . Dr. Gauthier has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NovoNordisk. Dr. Gauthier has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen Canada. Dr. Gauthier has received personal compensation in the range of $5,000-$9,999 for serving as an officer or member of the Board of Directors for Sharon Francis Foundation . Dr. Gauthier has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JPAD. Dr. Gauthier has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Lundbeck Foundation . Dr. Gauthier has received publishing royalties from a publication relating to health care.
Muhtesem Gedizlioglu, MD No disclosure on file
Antonio Gil-Nagel, MD Dr. Gil-Nagel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biocodex. Dr. Gil-Nagel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EISAI . Dr. Gil-Nagel has received personal compensation in the range of $0-$499 for serving as a Consultant for GW Pharma. Dr. Gil-Nagel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Angelini Pharma. Dr. Gil-Nagel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EISAI. Dr. Gil-Nagel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GW Pharma. Dr. Gil-Nagel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PTC Therapeutics . Dr. Gil-Nagel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Stoke . Dr. Gil-Nagel has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Zogenix . Dr. Gil-Nagel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Angelini Pharma. Dr. Gil-Nagel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BIAL . Dr. Gil-Nagel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for EISAI . Dr. Gil-Nagel has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for GW Pharma. Dr. Gil-Nagel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Jazz Pharma. Dr. Gil-Nagel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for PTC Therapeutics . Dr. Gil-Nagel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB Pharma. Dr. Gil-Nagel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Zogenix . The institution of Dr. Gil-Nagel has received research support from Jazz Pharmaceuticals. The institution of Dr. Gil-Nagel has received research support from PTC Therapeutics. The institution of Dr. Gil-Nagel has received research support from Zogenix. The institution of Dr. Gil-Nagel has received research support from Agencia Estatal Innovacion.
Marianne Giroux No disclosure on file
Richard H. Gracely No disclosure on file
John R. Grothusen, PhD No disclosure on file
Vasko Gulevski, MD No disclosure on file
Padma S. Gunaratne, MD, FAAN No disclosure on file
Jurgen Haeussler, MD No disclosure on file
Mohammad Heder, MD No disclosure on file
Eric M. Hernandez, MD No disclosure on file
William J. Hicks II, MD Dr. Hicks has nothing to disclose.
Jeremy C. Hobart, MD Dr. Hobart has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Hobart has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi.
Christophe Hotermans, MD, PhD No disclosure on file
Lauren Hyland No disclosure on file
Gary W. Jay, MD No disclosure on file
Klaus Kallenbach No disclosure on file
Kevin M. Kelly, MD, PhD Dr. Kelly has nothing to disclose.
Hallie Kendis, MD No disclosure on file
Ahmad Khalifa, MD, FAAN No disclosure on file
Ismail A. Khatri, MD, MBBS, FAAN Dr. Khatri has nothing to disclose.
Jongyeol Kim, MD, MS, RPVI, RPNI, RVT, NVS Dr. Kim has nothing to disclose.
Elaine Kingwell, MD, PhD No disclosure on file
Volker A. Knappertz, MD Dr. Knappertz has received personal compensation for serving as an employee of Noema Pharmaceuticals . Dr. Knappertz has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for Sutura Pharmaceutical . Dr. Knappertz has received intellectual property interests from a discovery or technology relating to health care.
Stephen Krieger, MD, FAAN Dr. Krieger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Krieger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Krieger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Krieger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Krieger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG Therapeutics. Dr. Krieger has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Krieger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cycle. The institution of Dr. Krieger has received research support from Novartis. The institution of Dr. Krieger has received research support from Bristol Myers Squibb. The institution of Dr. Krieger has received research support from Biogen. The institution of Dr. Krieger has received research support from Sanofi.
Sabine Kuckert No disclosure on file
Carl Langefeld No disclosure on file
Patricia Limousin, MD No disclosure on file
Michael J. Lyerly, MD, FAAN Dr. Lyerly has nothing to disclose.
Shaneela Malik, MD Dr. Malik has nothing to disclose.
Jeffrey C. McClean II, MD, FAAN Dr. McClean has or had stock in Tesla.Dr. McClean has or had stock in Netflix. An immediate family member of Dr. McClean has or had stock in Nike.Dr. McClean has received personal compensation in the range of $0-$499 for serving as a Committee Member with 好色先生.
Gregg D. Meekins, MD, FAAN No disclosure on file
Sarah A. Morrow, MD, MSC, FRCPC, FAAN Dr. Morrow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono/Merck. Dr. Morrow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene. Dr. Morrow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Morrow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Morrow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SanofiGenzyme. Dr. Morrow has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen Idec. Dr. Morrow has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Novartis. Dr. Morrow has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche. The institution of Dr. Morrow has received research support from Celgene. The institution of Dr. Morrow has received research support from SanofiGenzyme. The institution of Dr. Morrow has received research support from Novartis.
Milind Narurkar, PhD, PharmD No disclosure on file
Kendall Nash, MD Dr. Nash has nothing to disclose.
Paul Nietert No disclosure on file
Daniel Olmsted No disclosure on file
David Orion No disclosure on file
Christopher J. Panarites No disclosure on file
Byung H. Park, MD No disclosure on file
Sandipan Pati, MD Dr. Pati has nothing to disclose.
Jennifer Pettiford No disclosure on file
Niphon Poungvarin, MD, FRCP No disclosure on file
D K. Prashantha, MD No disclosure on file
Massimiliano Prencipe, MD No disclosure on file
Maria Esmeralda Quartuccio No disclosure on file
Srinivas Rao No disclosure on file
Jomar S. Roberts, Sr., MD No disclosure on file
Rani A. Sarkis, MD, MSc The institution of Dr. Sarkis has received research support from NINDS.
Sara Schepp, MD No disclosure on file
Robert Schmouder No disclosure on file
Lakshmi Shankar, MD No disclosure on file
Douglas Y. Shapiro, MD No disclosure on file
Jaime E. Silva, MD No disclosure on file
Ann L. Silverman, MD No disclosure on file
Gen Sobue, MD Dr. Sobue has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Mistubishi Tanabe Pharma Corporation. Dr. Sobue has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Nippon Chemiphar Co., Ltd.. Dr. Sobue has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Mistubishi Tanabe Pharma Corporation. Dr. Sobue has received personal compensation in the range of $0-$499 for serving as an Expert Witness for Takeda Pharmaceutical Company Limited..
Sarah Song, MD, MPH, FAAN Dr. Song has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN.
Natividad Stover, MD Dr. Stover has nothing to disclose.
Shuichi Suzuki, MD, PhD No disclosure on file
Stephanie Syc-Mazurek, MD, PhD Dr. Syc-Mazurek has a non-compensated relationship as a Editorial Board Resident and Fellows Section with Neurology that is relevant to AAN interests or activities.
Gilda Tafreshi, MD No disclosure on file
Stephen B. Tatter, MD The institution of Dr. Tatter has received research support from Monteris Medical, Inc. The institution of Dr. Tatter has received research support from Arbor Pharmaceuticals. Dr. Tatter has received intellectual property interests from a discovery or technology relating to health care.
Douglas Valenta, MD No disclosure on file
James P. Valeriano, MD Dr. Valeriano has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for ucb. Dr. Valeriano has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for neurilis.
Brian A. Van Adel, MD, PhD No disclosure on file
Arun Venkatesan, MD, PhD Dr. Venkatesan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen Pharmaceuticals. The institution of Dr. Venkatesan has received research support from NIH. The institution of Dr. Venkatesan has received research support from U.S. DOD.
Ayesha N. Vohra, MD No disclosure on file
Christina V. Warner No disclosure on file
Michael J. Wells No disclosure on file
Andrew J. Westwood, MD, FAAN Dr. Westwood has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Healthcare Business Solutions UK. Dr. Westwood has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda.
Jack Wilberger, MD No disclosure on file
Marie Wolanin, MD No disclosure on file
Chaohua Yan, MD, PhD No disclosure on file
Xiaojun You, PhD No disclosure on file
Maria C. Ysrraelit No disclosure on file
Laura B. Zahodne No disclosure on file
Nassim Zecavati, MD, FAAN Dr. Zecavati has nothing to disclose.
Richard M. Zweig, MD No disclosure on file
Carolina Barnett Tapia, MD Dr. Barnett Tapia has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx. Dr. Barnett Tapia has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Janssen. Dr. Barnett Tapia has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Barnett Tapia has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Barnett Tapia has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NMD pharma. Dr. Barnett Tapia has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen. Dr. Barnett Tapia has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Barnett Tapia has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx. Dr. Barnett Tapia has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Barnett Tapia has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Barnett Tapia has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Barnett Tapia has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for argenx. Dr. Barnett Tapia has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Kaplan education. Dr. Barnett Tapia has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alexia. The institution of Dr. Barnett Tapia has received research support from Department of defense. The institution of Dr. Barnett Tapia has received research support from Muscular dystrophy canada. The institution of Dr. Barnett Tapia has received research support from MgNet. The institution of Dr. Barnett Tapia has received research support from NIH. The institution of Dr. Barnett Tapia has received research support from Cartesian. The institution of Dr. Barnett Tapia has received research support from Alexion. The institution of Dr. Barnett Tapia has received research support from Argenx. Dr. Barnett Tapia has received intellectual property interests from a discovery or technology relating to health care.
Patricia Calleja Castano No disclosure on file
Renzo Figari-Jordan, MD, FAAN Dr. Figari-Jordan has nothing to disclose.
Harry J. Gould III, MD, PhD No disclosure on file
Aurelie Ruet The institution of Aurelie Ruet has received research support from BIOGEN. The institution of Aurelie Ruet has received research support from ROCHE. The institution of Aurelie Ruet has received research support from SANOFI GENZYME. The institution of Aurelie Ruet has received research support from BMS. Aurelie Ruet has received personal compensation in the range of $0-$499 for serving as a Board member with Horizon therapeutic. Aurelie Ruet has received personal compensation in the range of $0-$499 for serving as a Board member with Alexion. Aurelie Ruet has received personal compensation in the range of $0-$499 for serving as a Speaker meeting with BIOGEN. Aurelie Ruet has received personal compensation in the range of $500-$4,999 for serving as a Speaker meeting with MERCK. Aurelie Ruet has received personal compensation in the range of $0-$499 for serving as a Speaker meeting with Sanofi Genzyme.
Roy E. Strowd III, MD, FAAN Dr. Strowd has received personal compensation for serving as an employee of Kaplan. Dr. Strowd has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Monteris Medical, Inc. Dr. Strowd has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novocure. The institution of Dr. Strowd has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SpringWorks . Dr. Strowd has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for 好色先生. The institution of Dr. Strowd has received research support from Southeastern Brain Tumor Foundation. The institution of Dr. Strowd has received research support from Jazz Pharmaceuticals. The institution of Dr. Strowd has received research support from National Institutes of Health. The institution of Dr. Strowd has received research support from Alpha Omega Alpha. The institution of Dr. Strowd has received research support from American Board of Psychiatry and Neurology. Dr. Strowd has received publishing royalties from a publication relating to health care. Dr. Strowd has received publishing royalties from a publication relating to health care.
Didier Deffond No disclosure on file
Arve Dahl, MD No disclosure on file
Shafiuddin Ahmed, MD No disclosure on file
Flemming W. Bach No disclosure on file
Vesna V. Brinar, MD, PhD No disclosure on file
Albi J. Chalissery, MD No disclosure on file
Piraye Serdaroglu, MD No disclosure on file
Shahamat Tauhid, MD Dr. Tauhid has nothing to disclose.
Iyavut Thaipisuttikul, MD No disclosure on file
Avner Thaler, MD The institution of Dr. Thaler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ABBVIE. The institution of Dr. Thaler has received research support from MJFF.
Wim Van Hecke, PhD Dr. Van Hecke has received personal compensation for serving as an employee of icometrix.
Joshua L. Goldstein, MD No disclosure on file
Yedatore S. Venkatesh, MD, FAAN Dr. Venkatesh has nothing to disclose.
Peter Sillevis Smitt, MD The institution of Dr. Sillevis Smitt has received research support from Euroimmun. Dr. Sillevis Smitt has received intellectual property interests from a discovery or technology relating to health care.
Osman Farooq, MD Dr. Farooq has nothing to disclose.
Oluwadamilola O. Ojo, MD Dr. Ojo has nothing to disclose.
Francesca Caso, MD Dr. Caso has nothing to disclose.
Adrienne N. Dula, PhD No disclosure on file
Anjail Sharrief, MD The institution of Dr. Sharrief has received research support from NIH. The institution of Dr. Sharrief has received research support from University of Houston . Dr. Sharrief has a non-compensated relationship as a Consultant with Abbott that is relevant to AAN interests or activities.
Katrina Peariso, MD, PhD No disclosure on file
Giuseppe Erba, MD No disclosure on file
David P. Harris, MD Dr. Harris has nothing to disclose.
Ana L. Calderon-Garciduenas, MD, PhD No disclosure on file
Varun Sethi, MD, PhD No disclosure on file
Carrie M. Hersh, DO, MSc, FAAN Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech_GN41791. Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme. Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol-Myers Squibb . Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon Therapeutics. Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genzyme. Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. Hersh has received research support from Biogen. The institution of Dr. Hersh has received research support from Novartis. The institution of Dr. Hersh has received research support from Genentech_GN41791. The institution of Dr. Hersh has received research support from PCORI. The institution of Dr. Hersh has received research support from Bristol Myers Squibb.
Wolfgang Muhlhofer, MD Dr. Muhlhofer has nothing to disclose.
Alexander Merkler, MD Dr. Merkler has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for The Neurohospitalist. Dr. Merkler has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for n/a.
Craig A. Williamson, MD The institution of Dr. Williamson has received research support from Xoran Technolies, LLC. The institution of Dr. Williamson has received research support from United States Department of Defense. Dr. Williamson has received intellectual property interests from a discovery or technology relating to health care.
John M. Taylor, MD Dr. Taylor has received personal compensation for serving as an employee of Cincinnati Children's Hospital Medical Center. Dr. Taylor has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for John Michael Taylor, Forensic Medical Consulting. The institution of Dr. Taylor has received research support from NINDS. The institution of Dr. Taylor has received research support from StrokeNet.
Alexander George No disclosure on file
Teddy S. Youn, MD Dr. Youn has nothing to disclose.
Matthew Schrag, MD No disclosure on file
Rachel Nolan Ms. Nolan has nothing to disclose.
Ravindra Arya The institution of Ravindra Arya has received research support from National Institutes of Health. The institution of Ravindra Arya has received research support from Cincinnati Children's Research Foundation.
Robert I. Thompson-Stone, MD, FAAN Dr. Thompson-Stone has received personal compensation in the range of $500-$4,999 for serving as a Krabbe Disease expert with Advisory Committee on Heritable Disorders in Newborns and Children (ACHDNC). Dr. Thompson-Stone has a non-compensated relationship as a Editorial Board Member with Neurology: 好色先生 Journal that is relevant to AAN interests or activities.
Rejean M. Guerriero, MD Dr. Guerriero has nothing to disclose.
Ramsey A. Falconer, MD, FAAN Dr. Falconer has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Abbott. Dr. Falconer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Falconer has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Amneal. Dr. Falconer has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for GE Health. Dr. Falconer has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Acorda. Dr. Falconer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Kyowa Kirin. Dr. Falconer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurocrine. Dr. Falconer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Supernus. Dr. Falconer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sunovion. Dr. Falconer has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Federal Trade Comission (FTC). Dr. Falconer has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Justice Department.
Burhan Z. Chaudhry, MD Dr. Chaudhry has received personal compensation for serving as an employee of Bristol Myers Squibb.
Chindo B. Mallum, MD Dr. Mallum has nothing to disclose.
Giorgia Querin, MD No disclosure on file
Gabriela Cohen, MD No disclosure on file
Sharon Chiang, MD, PhD Dr. Chiang has stock in EpilepsyAI. Dr. Chiang has received research support from UCSF Clinical and Translational Science Institute UL1 TR001872. The institution of Dr. Chiang has received research support from NIH R25 NS070680 .
Adrian Laxton No disclosure on file
Alessandro Meani Alessandro Meani has nothing to disclose.
Ines Kobor No disclosure on file
Joshua Hersheson, MBBS No disclosure on file
Judith Eisele No disclosure on file
Kamalini G. Ranasinghe, MD, PhD Dr. Ranasinghe has nothing to disclose.
Luigi Lavorgna Luigi Lavorgna has nothing to disclose.
Tim-Henrik Bruun, PhD No disclosure on file
Shyamal Mehta, MD, PhD, FAAN Dr. Mehta has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Adamas Pharma. Dr. Mehta has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbott. Dr. Mehta has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for CNS Ratings.
Hane Lee, PhD Dr. Lee has nothing to disclose.
Igor T. Gavrilovic, MD Dr. Gavrilovic has nothing to disclose.
Mihaela Vlaicu Bustuchina, MD No disclosure on file
Toomas Toomsoo, MD Dr. Toomsoo has nothing to disclose.
Justin M. Nolte, MD Dr. Nolte has nothing to disclose.
Alexis N. Simpkins, MD, PhD, MSCR, FAHA, FANA, FAAN Dr. Simpkins has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for National Institute of Neurological Disorders and Stroke Data Safety Monitoring Board. Dr. Simpkins has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Stroke: Vascular and Interventional Neurology. Dr. Simpkins has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Bayer HealthCare Pharmaceuticals Inc.. The institution of Dr. Simpkins has received research support from NIH/NIA. The institution of Dr. Simpkins has received research support from Bristol-Meyer Squibb Foundation. The institution of Dr. Simpkins has received research support from Corxel. Dr. Simpkins has received publishing royalties from a publication relating to health care. Dr. Simpkins has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Vasculearn .
Sam H. Horng, MD, PhD The institution of Dr. Horng has received research support from National Institutes of Health . The institution of Dr. Horng has received research support from Jayne and Harvey Beker Foundation .
Malle Alilender, MD No disclosure on file
ANA MARIA IGLESIAS MOHEDANO, MD No disclosure on file
Anna Bjornsdottir, MD No disclosure on file
Niamh Cawley, MD No disclosure on file
Danah Marafie, MD Dr. Marafie has received research support from United States National Institute of Health.
Brian Ellison No disclosure on file
Melisa Valmoria No disclosure on file
Leonardo Almeida No disclosure on file
Lucas M. Araujo, Sr., MD No disclosure on file
Amanda D. Tomlinson No disclosure on file
Michael Shaw No disclosure on file
Osman Sezerman No disclosure on file
Amina Nasri, MD Dr. Nasri has nothing to disclose.
Aran Groves, MD, PhD No disclosure on file
Ayman Alboudi, MD Dr. Alboudi has nothing to disclose.
Addie Patterson, DO Dr. Patterson has received personal compensation in the range of $500-$4,999 for serving as a Content creator with Medical insights group.
Teresa L. Jacobs, MD, FAAN No disclosure on file
Antonio Daniele No disclosure on file
Ava L. Liberman, MD Dr. Liberman has nothing to disclose.
M.Purificacion Salmeron Ato, MD No disclosure on file
Kristopher M. Kowal, MD No disclosure on file
Ignazio Roberto Zarbo No disclosure on file
Michael A. Lopez, MD, PhD No disclosure on file
Chiara Zecca, MD Prof. Zecca has nothing to disclose.
Valentin Mateos Marco, Sr., MD No disclosure on file
Tanya Gurevich, MD Dr. Gurevich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medison, Abbvie, Teva, Neuroderm . Dr. Gurevich has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medison, Abbvie, Teva, Neuroderm, Truemed . Dr. Gurevich has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medison, Acino Ukraine, Abbvie. The institution of Dr. Gurevich has received research support from Parkinson's Disease and Movement disorders society .
Sebastiano Galantucci Mr. Galantucci has nothing to disclose.
Varun Chauhan, MD No disclosure on file
Francisco E. Gomez III, MD No disclosure on file
Daniel Moreno-Zambrano, MD Dr. Moreno-Zambrano has nothing to disclose.
Deepti Sharma No disclosure on file